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   Lauralle ja Martille
   “Give Me a Place to Stand and I will Move the Earth”
   A remark of Archimedes quoted by Pappus of Alexandria
ABSTRACT
Dioxins (polychlorinated dibenzo-p-dioxins, dibenzofurans and dioxin-like 
polychlorinated biphenyls)  are pervasive  and biomagnifying  environmental contaminants, 
to which  people are generally  exposed through foods of animal origin; in Finland,  a  major 
source is some fatty  fish  species of the Baltic Sea.  The dioxins, especially  the most potent 
of them, the 2,3,7,8-tetrachlorodibenzo-p-dioxin  (TCDD), are often  called “super  poisons”, 
based on  their  extreme acute toxicity  to laboratory  animals and feared long-term  effects in 
humans. Children,  before and after  birth, are especially  susceptible to this toxicity, 
possibly  induced by  picogram  daily  exposures,  while the risks to adults are less certain  and 
appear, for  example in  Finland,  to be outweighed by  the beneficial effects of fish 
consumption.  Furthermore,  the most  important  endpoints of dioxin  toxicity  have not been 
fully  untangled,  and even  the mechanisms of the most sensitive developmental effects 
have not been thoroughly elucidated.
After  gaining  access to the body, the dioxins bind to a  specialised intracellular  aryl 
hydrocarbon  receptor  (AHR), directly  influencing  the expression  of a  substantial number 
of genes.  The AHR,  a  transcription factor with  no established endogenous ligand,  first 
“converges”  the dioxin  effects, but then diverges them  depending  on  the affected species 
and even  the strain,  as well as the gender,  age and developmental stage of the individual. 
This divergence is exemplified in  the dramatic variability  of the acute toxicity  of TCDD 
even  within  one species: Han/Wistar  (H/W)  rats tolerate over  1000-fold larger  dioxin 
doses than  the Long–Evans (L–E) strain, almost solely  depending  on a  minor  structural 
difference in  the ARH. In  addition, TCDD toxicity  develops slowly  and is manifested 
differently  in  various laboratory  animals.  A  unifying  feature of acute TCDD intoxication  in 
many  species,  however,  is a  dramatic feed intake reduction  and weight loss,  termed the 
wasting  syndrome,  which  seems to be related to direct or  indirect  derangement of the 
central  regulation  of feeding. Clarification of the mechanisms behind the wasting 
syndrome would thus yield information on  an  important  facet of acute dioxin  toxicity  and 
open  the way  to using  TCDD as a  molecular  tool  to study  the physiology  of feed intake and 
body weight regulation.
In  this research, a straightforward approach  was selected to tackle the patho-
physiological challenge of wasting. The aforementioned strain  difference was utilised to 
address the AHR function,  and gene expression measurements were targeted at  the 
hypothalamus, the essential food intake and body  weight  regulator in  the brain. In  the first 
part of the thesis research, alterations in  the AHR signalling  cascade and some related 
proteins as well  as food intake-related neuropeptide neurotransmitters and their  receptors 
were measured using  quantitative reverse transcription PCR (RT-qPCR).  In  the latter, 
methodological  part,  some intricacies of the RT-qPCR technique were considered: The 
reproducibility  of the poorly  controllable reverse transcription  (RT) of RNA  to cDNA is a 
major determinant  of the reliability  of expression  analysis, and toxicological  studies 
involving TCDD have particular  difficulty  in  discovering treatment-unaffected stable 
mRNA  transcripts, reference genes, that can  especially  be used to reduce RT  variation. In 
the two expression  studies, the mRNA  levels of AHR-related proteins and feeding 
regulatory  factors were measured from  hypothalamic blocks at  6, 24  or  96  hours after 
TCDD doses that generated only  a  minor  reduction  in  feed intake in  the resistant H/W 
rats,  but  induced a  marked reduction in  feed intake and body  weight  (and would have 
eventually  led to lethality)  in  the sensitive L–E strain.  In  the two methodological 
experiments, a  set of stable reference genes was first sought  among the extensive and 
divergent expression  changes induced by  AHR activation, and then  the identified 
reference genes were employed in  a study  comparing  the robustness of various RT and 
qPCR enzymes and mapping the RT-qPCR variation sources.
There were small  constitutive differences in  the hypothalamic mRNA  expression  of 
some AHR signalling  cascade molecules between  L–E and H/W rats, but  these were most 
likely  not  causally  related to the development  of the wasting  syndrome.  A  functional AHR 
signalling  cascade seems to be present  in  the hypothalamus,  as shown by  the pronounced 
induction of cytochrome oxidases and Ahrr, an  AHR signalling  repressor  protein. 
However,  the magnitude and importance of cytochrome induction  in  neurones should be 
determined, employing anatomically  more detailed sampling.  The lack of any  drastic up- 
or  downward changes in  hypothalamic neuropeptide or receptor  mRNA  following  TCDD 
treatment and the stability  of hypothalamic reference gene expression  speak against  a 
severe cytotoxic  effect on, or  permanent hyperexcitation  of the cells taking  part  in  eating 
regulation.  A  late elevation  of some orexigenic (feeding  inducing) factors brought  about by 
TCDD seems to be a compensatory reaction to body weight loss.
Notably, the employed hypothalamic  block  sampling  may  cause expression  changes 
confined to a  localised point and/or  circadian  time to elude detection, and the complex 
neurophysiology  and anatomy  of the hypothalamus may  lead to reciprocal  cancellation  or 
dwindling of alterations. In  addition, the somewhat  divergent feeding  and energy  balance 
regulation between  L–E and H/W  rats also warrants further  research,  and as a  more 
general  question,  the importance of the hypothalamic  neuropeptides in  relation to other 
systems in eating regulation has not been definitively resolved.
The number  of genes displaying an  acceptable steadiness of expression in  the face of 
lethal TCDD toxicity  is small;  four  transcripts (Actb,  Gapdh,  Pgk1  and Sdha) were 
satisfactory  for  the hypothalamus,  and besides the expression  constancy, RT stability  was 
found to have a  strong  influence on the usability  of the potential  reference genes.  Hence, 
the use of only  one steadily  expressed but unstably  reverse transcribing  reference gene 
(Actb) has most likely  not induced marked bias in  the results attained in  the hypothalamic 
expression  studies, but  it may  have inadvertently  increased variation. Furthermore, RT 
variance markedly  exceeded qPCR variance,  stressing  the importance of replication  at  the 
RT  level, while the practical  consequences of differences in  the reproducibility  of the 
individual qPCR enzymes appear to be of little significance. On  the contrary, salient 
differences were noted between replicate PCR runs, and these should be taken into 
account in  the design  and data  analysis of RT-qPCR experiments.  Finally,  the use of linear 
hierarchical  models and Bayesian  inference was found to offer  the possibility  to build a 
coherent  statistical model of the whole RT-qPCR experiment  with  normalisation over  all 
expression measurements, thereby maximising the use of the data.
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LIST OF ABBREVIATIONS
Agrpa Agouti related protein homolog (mouse)
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Ahrr Aryl-hydrocarbon receptor repressor
Aip  Aryl-hydrocarbon receptor-interacting protein, also XAP2 or ARA9
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bHLH/PAS Basic  Helix-Loop-Helix / homologous region  of PER, ARNT  and SIM 
 proteins
BLA  Basolateral amygdala
CART Cocaine- and amphetamine-regulated transcript; gene Cartpt
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CV  Coefficient of variation
cDNA  Complementary DNA
CTA  Conditioned taste aversion
CRF Corticotropin releasing factor
Cck  Cholecystokinin
Cyp1a1 Cytochrome P450, family 1, subfamily a, polypeptide 1
Cyp1a2 Cytochrome P450, family 1, subfamily a, polypeptide 2
Cyp1b1 Cytochrome P450, family 1, subfamily b, polypeptide 1
2,4-D 2,4-Dichlorophenoxyacetic acid
DA  dopamine
2DG 2-deoxy-glucose
DMH Dorsomedial hypothalamic nucleus
DRE Dioxin response element
EROD Ethoxyresorufin O-deethylase (activity)
GABA  γ-aminobutyric acid
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GLUT1  Glucose transporter type 1; gene Slc2a1
Ghsr Growth hormone secretagogue receptor, ghrelin receptor
HSP90 Heat shock protein 90
5-HT 5-hydroxytryptamin, serotonin
H/W Han/Wistar rat strain
IC Insular cortex
Insr Insulin receptor
LHA  Lateral hypothalamic area
LD50 Median lethal dose
L–E Long–Evans rat strain
LOAEL Lowest observable adverse effect level
MCH Melanin-concentrating hormone; gene Pmch
2
Mc4r Melanocortin 4 receptor
Mc3r Melanocortin 3 receptor
M-MLV  Moloney murine leukaemia virus
α-MSH α-melanocyte-stimulating hormone; gene Pomc
Npy Neuropeptide Y
Npyr5 Neuropeptide Y receptor Y5
NTS Nucleus tractus solitarii
NAc Nucleus accubens
p23  A co-chaperone in the unligated AHR complex; gene Ptges3
PBN Parabrachial nucleus
Per1 Period homolog 1 (Drosophila)
Per2 Period homolog 2 (Drosophila)
Pmch Pro melanin concentrating hormone; peptide MCH
PCB Polychlorinated biphenyl
PCDD Polychlorinated dibenzo-p-dioxin
PCDF Polychlorinated dibenzofuran
Pomc Proopiomelanocortin; propeptide for several derived peptides e.g. 
 α-MSH
POP Persistent organic pollutant
PVN Paraventricular nucleus
qPCR Quantitative real-time PCR
RT  Reverse transcription
RT-qPCR Quantitative real-time reverse transcription PCR
SCN Suprachiasmatic nucleus
SD Sprague–Dawley rat strain
sd Finite-population (sample) standard deviation
Sim1 Single-minded homolog 1 (Drosophila)
SMR Standardised mortality ratio
SON Supraoptic nucleus
TAD Transactivation domain in the carboxyl-terminal of the AHR
TCDD 2,3,7,8-Tetrachloro-dibenzo-p-dioxin
TEF Toxic equivalency factor
TEQ TCDD equivalent quantity
2,4,5-T 2,4,5-Trichlorophenoxyacetic acid
TSH Thyroid-stimulating hormone, thyrotropin
VMH  Ventromedial hypothalamic nucleus
VTA  Ventral tegmental area
a  Equivalent  gene and protein  symbols, e.g.  Ahr/AHR,  are written  here in  their  gene 
symbol form; italicised and capitalised.  Conventional protein  designations (generally 
uppercase letters) have not been modified.
Symbols and gene nomenclature: Rat  Genome Database Web Site,  Medical College of 
Wisconsin,  Milwaukee,  Wisconsin.  WWW (URL: http://rgd.mcw.edu/).  Retrieved 
October 2012.
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1 INTRODUCTION
Dioxins (polychlorinated dibenzo-p-dioxins, dibenzofurans and dioxin-like 
polychlorinated biphenyls)  are known by  name and reputation  as “super  poisons”  based 
on  their  acute toxicity  and teratogenicity  to laboratory  animals [1, 27, 270], irrefutable 
adverse effects on humans after  occupational or accidental  exposures,  and feared long-
term  effects of picogram  doses [400].  Historically, understanding of dioxin  risks and the 
control  of human exposure  has walked hand in  hand with  the understanding  of their 
mechanistic toxicology, the development  of analytical  methodology  and the “chemical 
awakening” of the society.
Dioxins emerged as industrial contaminants, extremely  potent but  mainly  related to 
workplace accidents and chloracne in  the chemical industry  (and to a  massive chicken  feed 
contamination  in the southern  USA) [89, 111, 325].  In  the early  to mid-1970s, however, 
they  came to be of more general concern  due to their  effects on  people following  accidents, 
especially  after  a  chemical  plant  explosion  in  Seveso, Italy  (1976),  as well as environmental 
pollution  and human exposure through  dioxin-containing chemicals and products or 
industrial waste.  An example is the notorious defoliant  Agent Orange used in  the Vietnam 
War and a  waste  oil accident at  Times Beach, Missouri [135, 320].  Finally, during  the last 
20 to 30  years (in  conjunction  with  the decreasing  releases),  the dioxins have generally 
been  regarded as pervasive,  trace-level environmental contaminants with  feared long-
term  effects and unknown limits of safe exposure, and have also transpired as model 
molecules to investigate the physiological processes of environmental adaptation.
Mechanistically, the most  intriguing aspects of dioxin  action  are the specialised aryl 
hydrocarbon  receptor  (AHR) conveying and combining the effects of dioxin-like 
substances [252],  and the subsequent divergence of these effects,  depending at  least on  the 
structure of the receptor  of the affected species and strain, as well as the gender,  age and 
developmental  stage of the individual [270]. AHR is a  cytoplasmic transcription  factor  of 
the basic helix-loop-helix  (bHLH)/PAS receptor  family, which  upon binding  an agonist, 
e.g.  a dioxin  molecule,  is transferred to the nucleus and attaches to specific  DNA 
sequences, regulating a  diverse set  of genes and interacting  with numerous other 
transcription  factors [349].  Remarkably, the AHR appears to have a  similar  role in  all 
eutherian mammals [119] with  an  astonishingly  wide repertoire of functions and 
promiscuity  towards various environmental and endogenous substances,  but  without a 
known true endogenous ligand [65].  Furthermore, although  the dioxin  signalling  cascade 
up to DNA  is generally  well understood, little is known  of the intervening  cellular  and 
physiological steps between  the DNA  binding  of the activated AH receptor  and the 
endpoints of toxicity.
The discovery  of the AHR has had profound consequences for  both  regulatory 
toxicology  and toxicological research: It has enabled the development  and use of the toxic 
equivalency  factors (TEF) in  dioxin  risk assessment  and regulation [364], and 
consolidated the utilisation  of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), the most 
potent  dioxin  congener, as the reference substance in  experimental  studies and in 
regulatory  toxicology  [124].  Importantly, it  also has shifted the focus of mechanistic 
studies from  TCDD toxicity  to ARH-relayed toxicity  and AHR-related physiology  in  the 
species, strain, age and tissue context [97].
4
The diverging  effects of dioxin  are exemplified in  the dramatic  variability  and 
distinctive features of acute toxicity  of TCDD in experimental animals: Hamsters tolerate 
over  1000-fold larger  doses than  guinea pigs [273], and strikingly,  there is an  equally 
extensive difference between two rat  strains, Long–Evans and Han/Wistar, depending  on 
the ARH structure [283]. Besides the genetic background,  gender  influences TCDD 
susceptibility, even  affecting  it in  an opposite way  in different  species [272]. 
Characteristically,  acute TCDD toxicity  develops slowly  and death  does not  ensue until 1  to 
8  weeks after  even  a large TCDD dose. In  many  species it  is preceded by  a  dramatic weight 
loss,  the wasting  syndrome, which  might be related to direct  or  indirect  derangement  in 
the central regulation  of feeding  [212]. Nonetheless,  while wasting  is the major contributor 
to death  in  TCDD toxicity  studies in  rats, it  is not  necessary  for  lethality, and the critical 
target  tissues and physiological systems for  the acute lethal effects of TCDD thus remain to 
be established.
Untangling the mechanisms of wasting syndrome provides information  on an 
important facet of acute dioxin toxicity  and sheds light on  some of its processes, from 
transcription  to pathology. An additional  benefit is the possibility  to use TCDD as a 
toxicological tool in  physiology  to study  feed intake and body  weight regulation. The 
straightforward approach  to tackle this pathophysiological  challenge, starting  from 
transcription  alterations,  is to use the differences between  rat strains to address AHR 
functioning  and quantify  altered gene expression  by  measuring  mRNA  transcripts of the 
factors relating  to feed intake and body  weight  regulation. These preliminary  surveys at 
the mRNA level would then pave way  to more focused or  functional experiments, for 
example expression  measurements at  the protein  level,  chemical analysis of 
neurotransmitters or  studies concerning  nerve cell  activation.  However, much of the value 
of these more advanced analyses is lost  if they  cannot be targeted at  the right  molecules 
and CNS nuclei based on reliable mRNA expression data.
Quantitative real-time reverse transcription  PCR (RT-qPCR)  is currently  the most  agile, 
cost-effective and sensitive method to reproducibly  measure a  limited number of RNA 
targets from  a  large number  of tissue samples [398].  In RT-qPCR,  RNA  is first  reverse 
transcribed to cDNA  and then quantified using real-time PCR [43],  and this two-step 
process induces some challenges to the precision  of the measurements: The fidelity  of the 
cDNA  synthesis step is a major  determinant of reliable expression  analysis [46, 185],  and 
although  normalisation  of the genes of interest  to internal reference genes improves 
reliability,  it  still requires that  the relative efficiencies of the RT reactions for  the genes of 
interest and the normalisation  genes are consistent  from  reaction to reaction  [46]. 
Toxicological studies involving  TCDD have an  additional  difficulty  in  finding  stable 
reference genes among the extensive and divergent expression  changes induced by  AHR 
activation.
In  the first  part  of this thesis, the AHR-dependent  sensitivity  difference between  Long–
Evans and Han/Wistar  rats was employed to study  TCDD-induced wasting  syndrome and 
the changes in  hypothalamic  mRNA levels of factors relating to the AHR signalling 
cascade or  participating  in  feed intake and body  weight  regulation.  In  the second, 
methodological  part, potential  RT-qPCR reference genes for dioxin  studies were sought, 
and the robustness of various RT and qPCR enzymes was examined.
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2 REVIEW OF THE LITERATURE
2.1 DIOXINS AS ENVIRONMENTAL TOXICANTS
2.1.1 DIOXIN CHEMISTRY AND TCDD
“Dioxin”  is an  inexact  umbrella-term  for  a  group of chlorinated (chemically,  the organic 
frame could contain also bromine)  chemicals among  a  larger  family  of persistent  organic 
pollutants (POPs).  The dioxins,  or  “dioxin-like compounds”  – including  some 
polychlorinated dibenzo-p-dioxins (PCDDs),  polychlorinated dibenzofurans (PCDFs) and 
polychlorinated biphenyls (PCBs)  – are linked by  their  persistence and accumulation  in 
the food chain, and by  the planar  (flat) molecular  structure of their  two connected benzene 
rings with a  symmetrical  lateral  position  of at  least  four  chlorine atoms, facilitating high 
affinity  for  the aryl  hydrocarbon  receptor  (AHR) [6, 124, 285, 313, 403]. All dioxins thus 
convey  their  effects through  a  single receptor  and share the same basic  toxicity  mechanism 
[270]  (see 2.2).  The prototype of the dioxin group is its most  thoroughly  studied and most 
toxic  member,  TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin),  and each of the 
toxicologically  relevant PCDD,  PCDF and PCB congeners has been  assigned a  toxicity 
equivalence factor  (TEF) value in  relation to it [391].  TCDD was itself the key  molecule in 
the discovery  [284]  and characterisation [253]  of the AHR in the laboratories of Allan 
Poland and Allan Okey in the 1970s [97, 252].
Figure 1. Structures of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and dibenzo-p-dioxin. The TEF 
of TCDD is 1.
Notably, of the possible 75  PCDD and 135  PCDF compound structures,  only  7  dibenzo-
p-dioxins and 10  dibenzofurans bind to AHR with  sufficient affinity  to elicit marked AHR-
mediated biochemical  and toxic responses and thus be considered as dioxins [393, 394]. 
Each  chlorine substitute in  excess of the four  decreases the potency, but the toxic effects 
generally  remain the same. Of the 209  PCBs,  12  are deemed to be dioxin-like [394]: The 
four  non-ortho compounds, having  no chlorine substitute in any  position  next  to the inter-
ring C–C-bridge (positions 2,  2’,  6, 6’), are  the most potent as a  group, while  the eight 
mono-ortho PCBs have some activity, but roughly  thirty  thousand times weaker  than 
TCDD (Figure 2).  None of the other  PCBs induce dioxin-like effects due to their  three-
dimensional structure; only  the non-ortho compounds are freely  rotating along  the C–C-
bridge, and more than one chlorine in any  of the o-positions beside the C–C-bridge makes 
it impossible for the molecule to assume a planar conformation required for AHR binding.
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Figure 2. Structures of dibenzofuran, 2,3,4,7,8-pentachlorodibenzofuran (2,3,4,7,8-PeCDF), 
biphenyl and 3,3’,4,4’,5-pentachlorobiphenyl (3,3’,4,4’,5-PentaCB; PCB  126). The TEF of 2,3,4,7,8-
PentaCDF (the most potent furan) is 0.3 and that of 3,3’,4,4’,5-PentaCB (the most potent PCB) is 
0.1.
The operative  definition  of dioxin-like compounds also excludes a  number  of other 
coplanar  aromatic  halogenated hydrocarbons (polychlorinated azobenzenes and 
azoxybenzenes, polychlorinated naphthalenes, or  polybrominated and mixed [both 
chlorine- and bromine-containing]  dioxins, furans and biphenyls)  that bind to the 
“promiscuous”  AHR [65,  287,  315,  394].  However,  data  on  human  exposure and the 
toxicity  of these compounds is still scarce,  and by  and large the inclusion of some of them 
in  the dioxin group would not  markedly  alter  the logic of the dioxin definition  and TEF 
assignment  [366].  On the other  hand, the consideration of a  large number of natural and 
ubiquitous [64] non-halogenous AHR agonists and partial  agonists [65,  316] would make 
the definition of dioxin-like compounds very complex [366].
2.1.2 SOURCES AND EXPOSURE
Chlorinated dibenzo-p-dioxins and dibenzofurans (collectively  PCDD/Fs) have never  been 
intentionally  manufactured except  for  research purposes,  but are generated as by-
products or  impurities in  chemical syntheses, metal smelting,  refining  and processing,  as 
well  as in various forms of combustion, and during  the heating  or  burning of PCBs [146, 
187,  384].  The best known  contaminated products are surely  the herbicide 2,4,5-T  (2,4,5-
Trichlorophenoxyacetic  acid) and Agent  Orange (a mixture of 2,4,5-T  and 2,4-D).  In 
contrast,  the PCBs, technical mixtures with  variable amounts of dioxin-like PCBs and 
PCDD/F contaminants, were produced in  high  volumes, totalling  over  1.3  million  tonnes, 
and extensively  used from  the 1930s to the 1980s (no known  production  after  1994) for  a 
vast  number  of functions,  e.g. as hydraulic,  heat transfer  and lubricating  fluids; as 
dielectric  and coolant  fluids in  capacitors and transformers; and as plasticisers or 
additives in  plastics, paints, rubber  products, building  caulk  and building  sealants,  among 
other products. [33, 35].
Generally,  the releases and environmental  levels [303] of PCDD/Fs have markedly 
decreased in  industrialised countries during  the last  three decades; there was an 
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approximately  90% reduction in  their  releases in  the US between 1987  and 2000  [384], 
and emissions from  the most important sources were estimated to have decreased by 
roughly  the same extent  in  the EU from  1985  to 2005  [298]. The reduction of PCCD/Fs is 
mainly  attributed to the abatement of releases from  municipal waste  incineration  and 
from  other  large-scale incineration  facilities, cessation  of the use of chlorine gas in  pulp 
bleaching,  and the banning  or  strict  restriction  of the use of products containing  PCCD/F 
impurities, e.g. chlorophenols,  chlorophenoxy  herbicides and PCBs.  Examples of the 
remaining dioxin  sources,  in addition  to old-fashioned incinerators,  iclude steel and iron 
production [162], forest fires and the burning of solid fuels, principally  wood, and of 
agricultural  residue,  mainly  straw  [81, 187, 298],  as well  as the recycling  of electrical 
devices [400]. Common, unintentional  fires in  landfills also produce dioxins [78,  81]. 
Since PCBs are no longer  produced, their  atmospheric  release is mostly  related to 
emissions from  dumpsites and landfills (including fires),  the burning of PCB-containing 
material,  and releases from  large capacitors in  fires and at disposal. Consequently, the 
releases of PCBs have rapidly  decreased,  and have levelled off during  the last  10  years, 
with  an expected gradual disappearance in  20  to 40  years, probably  sooner,  in  western 
countries [34, 69].
Dioxin-like compounds are almost  solely  broken  down  in  the environment  by 
ultraviolet radiation and biodegradation  and remain  stable for  decades,  even  millennia,  in 
deep soil and sediments [337].  Being  extremely  poorly  soluble in water, deposited PCDD/
Fs and PCBs are considered not to markedly  accumulate in  most terrestrial plants [308, 
404] or  to be widely  released to the aquatic  biota  [402],  but after gaining  access to the 
biosystem  they  readily  bioaccumulate and biomagnify  in the food chain  due to their 
supreme lipophility  and slow  metabolism  in mammals [392].  Humans are exposed to 
dioxin-like chemicals through  food of animal origin  (and nowadays rarely  through 
industrial exposure), while the main sources (meat,  milk  or  fish) vary  depending  on the 
country and composition of the diet [209].
The most  recent  studies from  western  Europe, exemplified by  reports from  Sweden 
[382],  France [338] and Belgium  [410], estimate  the mean  daily  intakes of PCDD/Fs and 
dioxin-like PCBs to be around 0.7  pg/kg  (TEQWHO-98; TCDD equivalent  quantities 
calculated using  TEFs), and to have been  reduced by  a factor  of 2  to 3  in  5–10 years.  This 
appears to be in  line with  an  earlier  Finnish  study  (sampling  in 1997–9),  in  which  the 
mean  daily  intake was found to be 1.5  pg/kg TEQ [177]. Similarly  to food samples,  human 
breast milk  samples have shown a  dramatic  reduction  in  the dioxin  and PCB body  burdens 
since the 1970s [193, 250,  385],  although  the doses received by  the infants (15–150  pg/kg 
TEQWHO-98 per day  during  six  months of breast feeding  [385]) are still large in  comparison 
to food basked-based daily  intake estimates of adults. Human blood samples attest  to an 
increase in  PCDD/F and dioxin-like PCB concentrations with  increasing  age [178], 
explained by  the long half-life of the compounds [392],  and stress the importance of diet 
in  the exposure; Baltic  Sea  fishermen  consuming fish  at  least  twice a  week  exhibit over five 
times larger plasma  concentrations of PCDD/Fs than  the average Finnish population 
[179].  The amount  of food consumed in relation  to the body  weight  is also important, as 
shown in  children, who ingest  relatively  larger  doses of environmental contaminants than 
adults.  In a  recent  Finnish  study  (food sampling from  year  2002  to 2005),  the average 
intakes by  1-year-old children  were 1.1  pg/kg TEQWHO-98 per  day,  but almost doubled,  and 
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exceeded the previous estimate in  Finnish adults,  in  3- and 6-year-old children,  being 1.9 
and 1.8 pg/kg TEQ, respectively [163].
Dioxins are strictly  regulated.  The recent  chronic oral exposure reference dose (RfD; 
“not  likely  to cause harmful effects during a  lifetime”; tolerable daily  intake [TDI])  for 
TCDD assigned by  the United States Environmental Protection Agency  (US EPA) is below 
1  pg/kg  per day  [383],  and acceptable  levels of dioxins in foodstuffs imposed by  the 
European  union  are extremely  low  [82].  In  Finland, where fish  is the main source of 
dioxins [177],  the Finnish  Food Safety  Authority  Evira  has given  special recommendations 
for  the use the most dioxin-burdened Baltic  herring and wild Baltic salmon  to ensure the 
protection  of the most  vulnerable part  of the population, i.e. children  before and after 
birth [83].  Notably,  also much  more drastic  recommendations concerning  fish 
consumption have also been  given based on  pg/g  concentrations of these chemicals [136]. 
On the other  hand,  the risks imposed by  dioxin  intake appear  to be outweighed by  the 
beneficial  effects of fish  consumption, at  least  in  adults (as recently  considered in the 
population of Finnish  fisherman  in  ref [380]),  and the “excessive precautionary  advice”  on 
dioxins based on  epidemiological  data  has been seriously  questioned [370]. Furthermore, 
the most important endpoints of dioxin  toxicity  have not  been  fully  untangled [274], and 
even  the mechanisms of the most sensitive developmental effects have not  been 
thoroughly  elucidated [1,  405], placing  additional demands on  both  scientific  risk 
assessment and mechanistic toxicity studies [367].
2.2 AHR IN DIOXIN TOXICITY
2.2.1 BIOLOGY, STRUCTURE AND RELATED PROTEINS
The AH receptor  (Figure 3)  is a  ligand-activated transcription  factor  belonging to the 
bHLH/PAS (see below) protein  family,  the members of which  have important  roles in 
environmental adaptation; they  sense endogenous or  xenobiotic  small  molecules,  respond 
to hypoxia,  take part  in  the regulation  of neural development, participate in  the generation 
and maintenance of circadian  rhythms,  and many  act  as transcriptional partners and co-
activators [174, 225].  While firmly  attributed to conveying  the toxic effects of dioxins and 
induction of various xenobiotic  metabolising  enzymes [287], the AHR itself has an 
astonishingly  wide repertoire of important  physiological functions, from  liver 
development [147] and cell  cycle control [70] to the maintenance of gut-associated 
lymphatic  tissue [199].  Furthermore, it  is capable of binding  a  diverse array  of “classical” 
coplanar  and “nonclassical”  non-coplanar exogenous and endogenous ligands functioning 
as agonists and antagonists, suggesting  the existence of multiple endogenous ligands 
producing  unique cell- or  tissue-specific responses [65]. The diversity  of AHR responses to 
xenobiotic  stimuli is illustrated by  the vast  array  of gene expression  changes radically 
differing between species and even  between  rat  strains after  TCDD administration  [29, 
429].  Dioxin  toxicity  is thus intricately  bound to the position  of the AHR as a physiological 
and developmental regulator,  perhaps at  some point transforming  the TCDD from  an 
environmental “super toxicant” into a physiological tool [97].
The 20 proteins of the bHLH/PAS family  combine motifs from  two parent super 
families, bHLH and PAS (Per-Arnt-Sim),  making them  structurally  capable of both  DNA 
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binding  and protein  interaction  [3,  225]. Proteins of the large bHLH (basic  Helix–Loop–
Helix) super  family  often  function  as transcription  factors and share two highly  conserved 
and functionally  distinct  domains, making up a  region  of approximately  60 amino-acid 
residues.  At  the amino-terminal end of the HLH region  is the basic b domain,  which  binds 
the transcription  factor  to DNA, while the HLH  domain  is needed for  heterodimerisation 
of two bHLH/PAS proteins [3,  156]. The PAS acronym  stems from  the names of three 
genes: period (per),  a  Drosophila  melanogaster  clock gene; human  aryl hydrocarbon 
receptor nuclear translocator (ARNT),  a  component  of the dioxin  signalling pathway; and 
single-minded (sim), a  neurodevelopmental regulator in  D. melanogaster,  which  were 
noted to share sequence homology  in  a  domain  of 250–300 amino acids [225].  Currently, 
PAS refers to two (A  and B) homologous amino acid regions in  the original domain  that 
are important  for  the specificity  of the dimerisation  and other  molecular  interactions, 
including DNA  and ligand binding,  relating  to signal transduction [174,  219,  225]. In 
addition to the bHLH  and PAS domains,  the carboxyl-terminal  transactivation  domain 
(TAD)  is vital to AH-receptor  function. In  the extremely  TCDD-resistant H/W  rat, the 
binding  of TCDD to the AHR and the binding  of the receptor  complex  to the DNA occur 
normally,  but a  mutation  in  the Ahr  gene leads to alternative splicing of RNA, finally 
resulting  in  two types of deletion  in  the AHR protein  TAD [270,  285].  The resultant 
receptor  proteins seem  to be ineffective at initiating the  transcription  of some genes (and 
probably  repressing  others),  thus making the animals exceptionally  resistant to some 
aspects of dioxin toxicity (see 2.3.2).
Figure 3. Major functional domains of the AHR. The approximate locations of the regions 
responsible for DNA binding, ligand binding, HSP90 binding and heterodimerisation, as well as 
transactivation, are shown. The PAS domain comprises two subdomains, A and B. The 
transactivation domain has at least three subdomains (not depicted). Modified from [213, 219].
Besides the AHR signalling  cascade molecules (elaborated on  below), one member  of 
the bHLH/PAS family  is worth  mentioning. SIM1  (single-minded homolog  1  [Drosophila]) 
is a  critical regulator  of neuronal differentiation, expressed at  the highest levels in  the 
paraventricular  (PVN) and supraoptic  (SON) nuclei  of the hypothalamus [230] and at 
lower  levels in  the amygdala and lateral hypothalamic area  (LHA) [137].  Homozygous 
Sim1  mutants (Sim1  –/–) die perinatally  lacking  PVN and SON [230], because of failure of 
terminal  migration and differentiation  of the SIM1  neurons [423].  Intriguingly, Sim1-
heterozygous mice survive,  and develop hyperphagic obesity  [137],  which  is even 
enhanced in  conditional  postnatal  Sim1  homozygotes, both  exhibiting  a  marked decrease 
in hypothalamic oxytocin and PVN melanocortin 4 receptor (Mc4r) mRNA [362].
A 
Transactivation bHLH PAS domains 
B 
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2.2.2 AHR RECEPTOR SIGNALLING
he AHR is indispensable for  dioxin  action, most definitively  attested by  studies with 
AHR knockout  mice,  which  are unresponsive to all the major  effects of TCDD [85, 231, 
272,  429]. In addition,  there is a  good correlation  between  the toxicity  of the classic  dioxin 
congeners and their  binding  affinity  to the AHR [287,  315],  and in  C57BL/6J mice, 
congenic at the Ah locus,  a  10-fold difference in the binding  affinity  of the AHR to TCDD is 
associated with  a  sensitivity  difference of an  approximately  similar  magnitude to most of 
the toxic and biochemical effects of TCDD [26]. Moreover,  Ahr-mutated H/W  rats are up 
to 1000-fold more resistant to TCDD lethality  than  sensitive  rat (sub)strains (see above). 
Most  of the effects of dioxins are conveyed through a  “canonical”  AHR signalling  cascade, 
as demonstrated in  a  series of transgenic mutation experiments in  Christopher Bradfield’s 
laboratory, targeting  all the major  steps of the transduction: the translocation  of the 
ligand-activated receptor  from  the cytosol to the nucleus [41],  heterodimerisation  with 
ARNT  [391]  and DNA  binding  at specific sites, the dioxin  response elements (DREs) [40]. 
However,  besides the canonical pathway, the AHR has been found to employ  alternative 
signalling  routes. For  example, in  certain  cell lines,  ligand-activated AHR is alone able to 
repress oestrogen-regulated transcription  [192], and activate protein  kinases and 
ultimately  cyclo-oxygenase 2  [222].  In  addition, DRE binding  has been  shown  not to be 
involved in  the AHR-related induction  of acute-phase response genes in vitro  [259],  or  in 
the suppression of genes involved in cholesterol synthesis in vivo [357].
At the molecular  level,  canonical AHR signalling (Figure 4) is best  characterised by  the 
induction of phase I xenobiotic-metabolising enzyme CYP1A1  (recently  reviewed in  [18, 
213,  272]).  The unbound AHR resides in  the cytosol in  a  protein  complex  also containing a 
dimer  of heat  shock protein  90 (HSP90), aryl hydrocarbon  interacting protein (AIP; also 
XAP2  or  ARA9) and p23, which  enhance ligand binding,  stabilise  the AHR,  reduce 
spontaneous nuclear  translocation of the receptor  and regulate the signalling  in  a  complex 
manner  [59, 245]. Upon  ligand binding,  the AHR undergoes a  conformational change 
exposing  nuclear  localisation signal peptide sequences, and the protein  complex  is actively 
transported into the nucleus [148]. The AHR then  dissociates from  the chaperones and 
heterodimerises with  another  bHLH/PAS protein,  ARNT, and the dimer  binds to the DNA 
at  DREs [351]. AHR activity  is terminated by  nuclear  export  and ubiquitin-mediated 
degradation  of the receptor  [219,  288],  and the transcriptional activity  of AHR is 
constitutively  and inducibly  inhibited by  AHR receptor  repressor  (AHRR). This competes 
with  the AHR to form  a heterodimer  with  ARNT and directly  represses gene expression 
while binding to DREs [94].  Notably,  the mRNA transcription  of the Ahrr gene is 
generally  markedly  induced by  AHR receptor  stimulation,  while TCDD exerts only  a  minor 
influence on Ahr and Arnt mRNA  abundance [94,  143, 144, 274].  Brauze et  al.,  however, 
reported a  threefold increase in  Ahr mRNA  in  female SD rat liver  after  a  TCDD dose of 25 
μg/kg.  In  contrast, TCDD exposure accelerates AHR protein  degradation  (see before),  and 
concurrently  AHR is drastically  reduced in vitro  [105, 219,  288]. In vivo, AHR protein is 
initially  diminished but  then  displays a  tendency  towards recovery, the speed and extent of 
which  depend on  the rat  strain  and TCDD dose [92,  288]; recent  findings show  the 
depression to persist for up to 6 days in mouse liver [274].
Transactivation, the launch of mRNA transcription  after  DNA  binding, involves 
interactions of the AHR/ARNT dimer  with  a  large number  of transcriptional coactivators 
and other  transcription  factors, depending on tissue and even  on  single cells [18,  123]. 
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However,  little is known of the molecular  mechanisms of AHR activation-induced 
repression  of gene expression, although in  adult mice and rats it  does not  appear  to 
involve micro-RNAs [234, 430].  The complexity  and importance of the transactivation  in 
AHR-mediated dioxin  toxicity  is best  exemplified by  the extreme variability  in  the 
responses of H/W  rats and hamsters to TCDD, recently  thoroughly  discussed by 
Pohjanvirta  et  al. [272].  H/W rats harbour two forms of deletion  in  their  AHR protein 
transactivation  domains (see before),  but intriguingly  some of their  TCDD responses, 
termed type I,  are not  changed at  all (typically  the induction  of cytochromes,  thymus 
atrophy  and foetolethality), while other,  type II responses (e.g.  lethality,  liver  toxicity  and 
wasting  syndrome) are drastically  weakened [275, 335,  378]. The molecular mechanism  of 
this dual outcome is hypothesised to be related to the structural  alterations in  the mutated 
H/W AHR: The truncated TAD might  be less suited to interplay  with  the coregulators or 
other general  transcription  factors [272].  Alterations in  crosstalk  with  other  signalling 
pathways,  especially  oestrogen  receptor  signalling, which  is known  to cross ways with 
activated AHR even  before transactivation  [38], are also possible mechanistic 
explanations for the selective TCDD resistance of H/W rats [272].
Figure 4. A schematic and simplified diagram of the key steps of the canonical AHR signalling 
pathway. Dioxin binding to the AHR leads to its translocation into the nucleus, heterodimerisation 
with ARNT and binding to the DNA at DREs, with ultimately modulating expression levels of target 
genes. One of the gene products elevated by this mechanism is AHRR, which forms a feedback 
loop by inhibiting AHR action. Modified from [272].
2.2.3 SIGNALLING PATHWAY IN THE RODENT CNS
Studies in  rats and mice suggest  the AHR and other  key  proteins of the canonical AHR 
signalling  pathway  to be expressed in  the developing  and adult  mammalian CNS. In 
prenatal mouse, AHR and ARNT mRNA  and protein  were present  in  high  concentrations 
in  the neuroepithelium  of the developing  brain  around gestational days (GD) 10–12, but 
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then  started to diminish  with only  regional,  generally  lower  levels being  expressed after 
that;  in  the hypothalamus,  a  strong  Arnt mRNA signal was recorded at  GD11  and GD15  [2, 
7,  151]. In  comparison,  AHR immunoreactivity  was only  marginally  detected in  human 
foetal brains at 4  to 7  months of gestation,  however,  which  is far  past the embryonic phase 
terminating  at 8  weeks [153]. After  birth,  AHR protein  expression  was detected on 
postnatal day  1  in  primary  cortical  astrocytes and in  primary  cortical endothelial  cells from 
weanling mice [88], and in another  study  cerebellar  AHR protein  was shown  to be present 
at all time-points from birth to adulthood and ARNT from post-natal day 3 onwards [407].
In  rats,  Ahr and Arnt mRNA  has been  found pre- and postnatally  in  the hypothalamus 
[292],  and Ahr mRNA has been  detected in  virtually  all GABAergic (γ-aminobutyric  acid) 
neurons in  the preoptic area  on  postnatal  day  3  [125].  The adult  rat brain  exhibits wide 
Ahr and Arnt mRNA  expression,  with  especially  high  levels occurring  in  the caudal  part  of 
the arcuate nucleus (ARC) in  the hypothalamus [144,  159,  266], and there is also 
pronounced DRE binding  in the hypothalamus [189]. On  the other  hand, in adult mice, 
Ahr mRNA  levels in the brain  were about  10-fold lower  than in  the lungs, the tissue 
displaying the highest  expression  [208].  The data  regarding AHRR are somewhat 
conflicting. Huang  et  al.  [143] noted the basal Ahrr mRNA  abundance to be high  in  the 
mouse pituitary,  but  low  in  the cerebellum  and cortex,  and negligible in  the hypothalamus, 
whereas Bernshausen et  al.  [21]  found most Ahrr mRNA, among  the nine tissues 
examined, in  the brain and heart, and the expression  diminished by  two orders of 
magnitude in Ahr-deficient  mice,  indicating  a key  regulatory  role for  the AHR [21]. 
Furthermore,  strong  AHRR immunoreactivity  was seen in  the mouse hippocampus and 
cortex, and staining was recorded in  nuclei of several neurons throughout  hypothalamus 
[86].
The aryl hydrocarbon nuclear  translocator  2  (Arnt2) is a paralog  of Arnt whose 
expression  is primarily  confined to the brain in  adult mice [75,  134].  During  mouse 
development, the two genes show  a high  level  of overlap in  most organ systems,  while 
Arnt2 mRNA  is especially  intensively  expressed throughout the CNS [7]. In the rat 
hypothalamus, the highest expression  of Arnt2 mRNA  has been  found in  the SON and in 
the PVN, but  low  or  moderate levels have been detected in  most  other  hypothalamic 
regions [266].  The function,  if any,  of ARNT2  in  the classical (CYP1A1) AHR signalling 
pathway  is debated,  since it has the ability  to dimerise with  the liganded AHR in vitro  and 
is influenced by  the activating ligand, yet  appears to be limited in  its ability  to influence 
AHR-mediated signalling  in  cell culture  [74, 122, 331].  On  the other  hand, ARNT2  appears 
to function  in  close  connection with  SIM1  in neuronal development,  since homozygous 
Arnt2 mutants die perinatally  and exhibit an  identical hypothalamic defect to that 
observed in  homozygous Sim1 mutant (see before)  mice [170]. It  is postulated that 
heterodimerisation  with  ARNT2  is required for  SIM1  function  in  the developing 
hypothalamus [140, 170,  229],  and accordingly,  expression  of Sim1 has been  shown  to be 
regulated by AHR–ARNT2 and react to TCDD in vitro [428].
Induction of phase I and II xenobiotic-metabolising  enzymes has been shown to occur 
in  various regions of the rodent  brain  at mRNA,  protein and enzyme activity  levels, 
attesting  to the presence of a  functional  AHR signalling cascade in  the CNS [52,  139, 143, 
144, 386].  In Sprague–Dawley  (SD) rats, a  non-lethal dose of 10 μg/kg  TCDD brought 
about  a  fairly  uniform  induction of Cyp1a1 mRNA  throughout  the brain  up to 4  weeks 
after  exposure,  but the response was much weaker  in  the CNS than  in  the liver,  and no 
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CY1A1  or CYP1A2  protein was detected in the brain  with  Western  blotting  [144]. On the 
other hand, in  L-E and H/W  rats at 10 days after  5  or  50  μg/kg  TCDD, certain  regions of 
the brain  exhibited induction  of CYP1A1  activity  (measured as EROD [ethoxyresorufin  O-
deethylase] activity), whose magnitude was almost  comparable to that measured in  the 
liver  [386].  Treatment of SD rats with  another  AHR agonist  also led to the induction of 
both  Cyp1a1 and Cyp1a2 mRNA  in various regions of the brain  [323], while CYP1A1 
immunoreactivity  and catalytic activity  appeared to largely  localise in  choroid and 
arachnoid membranes [240]. Increased CYP1A1  and CYP1B1  protein (as well as three 
xenobiotic  efflux  pumps) was detected in  brain  capillaries from  SD rats 2  days after  1  or  5 
μg/kg  (i.p.) TCDD administration [397]. As to individual  cell  types in  the CNS, AHR 
agonist  administration  induced CYPA1A1  protein  expression in  endothelial cells of veins in 
mouse brain  and leptomeninges,  and in  the capillary  endothelium  of the choroid plexus, 
whereas CYP1B1  protein  was constitutively  expressed in  smooth  muscle cells of brain  and 
leptomeningeal arteries [110]. The CYP1A1  and CYP1B1  induction  response to TCDD has 
been  reported in  mouse primary  cerebellar  granule neuroblasts [407] and in  mouse 
cerebral vascular endothelial  cells, while in  astrocytes, CYP1B1  but not CYP1A1  was 
induced [88].
2.3 ASPECTS OF DIOXIN TOXICITY IN HUMANS AND ANIMALS
The toxicity  of dioxins,  principally  TCDD,  has been  addressed in  a  vast number  of 
epidemiological  investigations in  man  and experimental studies in  animals.  In humans, 
unequivocal  acute or  subacute dioxin  toxicity  has been  noted in  several  workplace 
exposures (subacute to chronic) and accidents in  the chemical industry, in an industrial 
accident  in  Seveso in  1976  and in  two incidents of direct food (rice oil) contamination: 
“Yusho”  in Japan  1968  and ”Yucheng”  in  Taiwan 1979, each  affecting  approximately  2000 
people [84,  141,  257,  262, 353,  403, 431].  Notably, few  signs of acute or  subacute toxicity 
were noted in  military  personnel applying  dioxin-contaminated phenoxyacetic-acid 
herbicides, mainly  Agent  Orange, in  Vietnam  during  operation Ranch  Hand [150], 
possibly explained by the length of time between exposure and assessment [403].
Epidemiological  data  and animal experiments both  attest  the developing  foetus and 
children  (combined with elevated exposure through  breast  milk)  to be very  susceptible to 
the acute and long-term  harmful effects of dioxins [84, 115, 141, 365, 403,  427].  The 
sensitivity  to cumulative high-dose prenatal exposure was most gravely  demonstrated in 
the Yusho and Yucheng catastrophes, where intrauterine growth  retardation,  low  birth 
weight, hyperpigmentation, neurological dysfunction, dental anomalies and alterations in 
sexual development were noted [84]. In  the latter  case, even  infant mortalities were 
recorded (8  deaths among  39  infants severely  exposed in utero  [141]). Sensitivity  to 
prenatal and infant  exposure is especially  well  characterised in tooth development defects 
at  minute chronic  doses [9, 408].  Accordingly,  the latest  authoritative TCDD risk 
assessment by  the US EPA  [383] relies heavily  on the lowest observed adverse effect levels 
(LOAELs) supplied by  epidemiological  studies relating  foetal  dioxin exposure to altered 
neonatal thyroid function  [12]  and acute  pre- and postnatal (up to puberty)  exposure to 
lowered adult  sperm  quality  [232, 233].  On the other hand, the relationship and dose 
response between  adult  chronic dioxin  exposure and the manifold suspected long-term 
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alterations and health  effects – especially  carcinogenicity  – are debated [1, 28,  145, 149, 
212, 322, 370, 381, 403].
2.3.1 ACUTE AND SUBACUTE HUMAN TOXICITY
Adult humans generally  appear  to be relatively  resistant to the toxic effects of dioxins after 
single or  short-term  exposure. In  three documented cases of accidental or  deliberate 
poisonings with  very  high  measured internal doses,  26  000–144  000  pg/g  serum  lipid 
(corresponding  to an  external dose of 6–25  μg/kg) of TCDD, the main  clinical signs were 
persistent chloracne and gastrointestinal  symptoms, but no permanent organ damage was 
reported [104,  321].  However,  in  the case of Mr. Yushchenko, followed from  the start  of 
the intoxication,  acute to subacute gastrointestinal inflammation, hepatitis and 
pancreatitis as well  as neuropathy  and arthritis lasting over  a  year  were detected [321]. 
Concurring  findings of chloracne and gastrointestinal  ailments, without  other apparent 
early  or mid-term  health  effects, were detected,  mainly  in  children,  in  Seveso following  a 
single (short-term)  exposure,  with  the highest  internal measured dose of 56  000 ppt  in 
serum  [23, 50].  Typically,  chloracne has been detected after  cutaneous exposure and with 
back-calculated concentrations of over  8000 pg/g  serum  lipid [322]  – but  sometimes even 
below  1000  pg/g [157,  353].  These estimates are,  however,  riddled with  various 
uncertainties and greatly variable exposure lengths.
In  Yusho and Yucheng (“oil disease”  in  Japanese and Chinese, respectively) poisonings, 
caused by  rice oil contaminated with  technical  PCB fluid,  the main  finding  in  adults was 
chloracne accompanied by  cutaneous and mucosal hyperpigmentation  and conjunctival 
discharge from  the Meibomian glands [141,  190].  Besides these, a  number  of symptoms 
and objective clinical alterations,  including  inconstant  abdominal pain,  were recorded for 
Yusho, but  no mortalities were  directly  attributed to acute  or  subacute toxicity  [190, 431]. 
However,  an  increase was noted in  standardised mortality  ratios (SMR) of diabetes 
mellitus and cardiovascular disease shortly  after  exposure in  a  recent epidemiological 
study  [165]. In  contrast,  few  clinical signs or  symptoms besides cutaneous changes were 
recorded (or  reported) in  adult Yucheng patients,  while 11  of them  died from  hepatoma, 
liver  cirrhosis or  liver  diseases during  a  4-year  follow-up period [141],  and a  significant 
increase in  SMR of chronic  liver  disease and cirrhosis during  the first seven  years after 
exposure was detected in  males [364].  Notably,  both  Yusho and Yucheng  patients were 
exposed to complex  mixtures of PCBs and PCDFs,  and estimated to have consumed 
roughly  1  g  of PCBs and 3–6  mg  PCDFs [114,  141,  190]  during  the incident.  Thus, non-
planar  PCBs have also been  suggested to have taken  part  in  the toxicity  [115],  although 
dioxin-like chemicals, mainly  2,3,4,7,8-penta-CDF (back-calculated concentration  in 5 
Yusho patients about 20 000 TEQ pg/g  serum  lipid) [220,  221], are  generally  considered 
to have been the principal toxicants [165, 166, 188, 257, 431].
2.3.2 ACUTE TOXICITY IN LABORATORY ANIMALS
In  laboratory  animals, the most  conspicuous features of the acute toxicity  of TCDD are 
delayed lethality, drastic and long-term  changes in  body  weight  and eating, and huge 
inter- and intra-species differences in  susceptibility  stemming  from  AHR structure (see 
2.2.) [274,  280]. Even  high  acute dioxin  doses do not  kill animals immediately, but  death 
occurs in  one to several weeks,  and in  many  species (e.g. rats, mice,  hamsters and guinea 
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pigs) after  substantially  reduced feed intake and prominent  weight  loss [99, 128,  171, 256], 
called the wasting syndrome. Lethal levels and those inducing  wasting vary  widely  among 
species and strains: The LD50 value of TCDD for guinea  pigs is 1–2  μg/kg,  and for  most 
rat  strains 20–50  μg/kg, but  the most  resistant  H/W rat  strain  may  tolerate more than 
10000 μg/kg.  In  mice,  the LD50  for  most strains ranges from  150 to 300 μg/kg,  but for  a 
resistant strain, DBA/2, it  is about  10 times higher.  The most  resistant  mammalian species 
is the hamster,  with  an LD50  of 1000–5000 μg/kg.  Gender  also affects sensitivity,  and in 
a  species-specific  manner.  Female rats are about twice as sensitive to the acute lethality  of 
TCDD as males,  but  in  contrast  to rats,  female mice are the resistant  gender, the 
divergence being  over  10-fold in  one tested substrain  [274]. Body  weight loss due to 
hypophagia  seems to be the principal reason  for  death  in  wasting syndrome-affected 
species [272].  However, additional  factors seem  to be at  play, since parenteral nutrition 
does not prevent lethality [98, 142].
The functional and morphological alterations in  experimental acute dioxin toxicity  are 
numerous and tightly  coupled with  the species,  strain,  gender  and age of the affected 
animal [27, 272, 275, 287, 327],  recently  summarised by  Pohjanvirta  et al. in  [274]. 
Notably, and in contrast  to humans, chloracne is a  very  unusual finding in  experimental 
animals, excluding  rhesus monkeys [224], and has only  been  induced in  hairless mice and 
rabbits, usually  by  topical administration  [293, 327]. In  brief,  TCDD is immunotoxic  [172] 
and a  potent  endocrine disruptor, lowering and/or  altering the circadian  rhythmicity  of 
several hormones and interfering  with  their  receptors through  AHR interaction  [38]. The 
underlying mechanism  of the disturbances in  hormonal levels may  also be accelerated 
metabolism  (thyroxine, melatonin),  impaired biosynthesis (testosterone, corticosterone) 
and adaptive or  compensatory  reactions and/or a  mixture of mechanisms (TSH,  insulin) 
[272]. There are also a  number  of changes in  clinical  chemistry  parameters,  many  related 
to liver function, but the changes are often species specific [272, 275].
Thymus, liver,  gastrointestinal tract  and testis are among the tissues showing 
morphological alterations in  acute TCDD toxicity  in  young adult  animals; however, the 
changes are again, excluding thymic atrophy  [93], highly  dependent  on the species studied 
[223, 275].  Surprisingly, after  30 years of intensive research, the critical target  tissue for 
the acute lethal  toxicity  of TCDD remains to be found [272].  The drastic adaptive CYP 
induction brought  about  by  minuscule dioxin exposure does not explain the toxicity,  as 
shown by  the similar  CYP1A1  response in  H/W  and L–E rats and Ahr-transgenic  mice 
[184,  270, 271],  and the dissociation  of the persisting CYP1A (EROD activity) induction 
from  the diminished acute toxicity  in  ARNT hypomorphic (having  a  low-expressing  Arnt 
allele)  mice [391].  In the mouse liver,  Cyp1a1 and Cyp1a2 induction through  the DRE 
cluster  even appears to offer  protection  against  acute dioxin-induced hepatocellular 
necrosis and hepatic inflammation  [252].  There might, however, be a  slight  indirect  effect 
of Cyp1a2 induction, since the CYP1A2  protein  accumulates TCDD in  the liver  of rats and 
mice [168, 390], and a  deficiency  of its gene leads to a  lower  hepatic TCDD concentration 
[72,  73], affording  partial protection against  hepatotoxicity  in  mice [340]. In  addition, in 
the mouse, CYP1A2  appears to play  a  causal role in  dioxin-induced hepatocellular 
hydropic degeneration, but not in inflammatory or necrotic changes [252].
The liver  is a central  and almost invariably  affected organ in  acute TCDD toxicity, 
suggested to show  the most  promise in elucidating  the fundamental biochemical and 
molecular  mechanisms of dioxin  action  [29], and hepatopathies have been  related to high 
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dose exposure in humans (see above).  The hepatotoxicity  also serves as an excellent, and 
the most studied,  example of the species-,  strain- and even  gender-specific  effects of 
TCDD and AHR physiology  at  the organ  level. Generally, the prominent  morphological 
liver  alterations in  dioxin  intoxication  are hepatocellular  hypertrophy, multinucleated 
hepatocytes (in  rats and hamsters), steatosis and inflammatory  cell  infiltration, as well  as 
scattered necrotic  foci,  and are accompanied by  respective serum  transaminase elevations 
depending  on  lesion  severity  [275]. The liver  lesions, however, differ  quantitatively  and 
qualitatively  among  species, and at  least  between the sensitive L–E and resistant  H/W  rat 
stains [273, 368]. Among mammals,  severe liver  necrosis might be directly  attributed to 
lethality  only  in  rabbits [223].  In  the most  TCDD-sensitive species, the guinea  pig,  lesions 
are conspicuously  mild  [116],  and rats generally  exhibit substantially  less liver  affection 
than  mice [275].  Recently,  a  drastic difference between  sexes in  TCDD liver  toxicity  was 
also shown  by  histology  in  mice; abundant  necrotic foci and a  purulent  inflammatory 
reaction were observed in  males, while  little necrosis accompanied by  a  granulomatous 
reaction was recorded in  females [274].  Microarray  studies concur  with  the crude 
histopathological  findings in  attesting  to a  surprisingly  different response to TCDD in  the 
mouse and rat liver  [30,  32].  Furthermore,  the number  of hepatic  genes affected by  TCDD 
is lower in  H/W  rats than  in TCDD-sensitive strains [91],  and different  rat strains/lines 
exhibit  dramatic transcriptional  heterogeneity  in their  hepatic  responses to TCDD, 
excluding some 10  classic  AHR-regulated genes,  such  as Cyp1a1,  Cyp1b1,  Nqo1 and Tiparp 
[31, 235, 429].
2.4 WASTING SYNDROME AND EATING REGULATION IN THE 
BRAIN – AN OVERVIEW
Derailment of the body  weight and food intake regulation  in  laboratory  animals, known  as 
the wasting syndrome, is a  highly  characteristic  effect of dioxins (mostly  studied in TCDD) 
but a  rare outcome of chemical exposure in  general. In  addition,  although firmly 
established as being  mediated by  canonical  AHR signalling,  the biochemical and 
pathophysiological basis of the ailment have remained elusive.  Below, I will address the 
salient features of dioxin-induced changes in  food intake in  connection  with  the central 
regulation of energy  balance. This selective discussion  is based on  our  recent  in-depth 
review on the subject [213].
2.4.1 GENERAL ORGANISATION OF FOOD INTAKE REGULATION
Animals and humans adjust the amount  of food eaten according to the caloric content of 
the nourishment,  their  energy  expenditure and long-term  energy  stores,  striving to 
maintain  an  energy  balance.  However,  this homeostasis seems to be biased towards an 
upward shift  in  favour  of excess adiposity, resulting  in  a new  balance that is then  defended 
[169, 241,  319, 333], and some models of intake regulation  even discard the notion  of an 
actively  defended homeostasis (see 2.4.3). An opposite shift  in  energy  balance towards 
reduced body  fat  and weight  seems much  less favoured [326], and is seldom  observed in  a 
physiological context, except for seasonal animals. When ample,  uniform  food is 
constantly  available, regular  eating patterns integrated with  other  behaviours are 
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established (the major ‘‘zeitgeber” being the light–dark cycle), and so-called distal cues 
(smell, taste, texture,  etc.) as well as preparatory  physiological alterations strongly 
regulate the size of meals [348, 416, 418]. In  contrast, in  “natural”  conditions this 
regulation is mixed with,  or  even  dominated by,  environmental influences and internal 
non-homeostatic functions and processes, such  as food reward,  satisfaction,  learning  and 
cognition  [241,  333]. Fittingly, human food intake regulation  is suggested to partly  consist 
of energy homeostasis and partly of “reward homeostasis” [344].
The central neuroanatomical  system  regulating  eating  is generally  accepted to reside in 
hypothalamic and brainstem  nuclei, amongst  a  myriad of connections with  other brain 
areas.  However, the primacy  of this system  as the integrator  of (long-term) energy 
balance, as opposed to a  more decentralised regulation, is debated [87,  241,  333]. In 
satiation-based food intake regulation,  the energy  balance sets the general sensitivity  of 
the hypothalamus – caudal  brainstem  (‘‘hindbrain”) system  to satiety  signals affecting  the 
meal  size; an  abundance of stored and circulating  nutrients enhances sensitivity  to the 
meal-terminating  signals [241,  249,  417]. On  the other  hand, the incentive (reward) value 
of palatable food can override satiety  signals and promote excess eating, aptly  termed non-
homeostatic food intake regulation. Here,  the reward itself contains several psychological 
components (liking,  wanting and learning) that correspond to distinguishable 
neurobiological mechanisms [22], with  partly  overlapping  and only  partially  known CNS 
circuits and signals [87, 191, 249, 333].
2.4.2 WASTING SYNDROME
The reduction  of body  weight in  dioxin-induced wasting  syndrome has been  shown to 
primarily  result  from  hypophagia  in  rats, mice and guinea  pigs [171],  and neither  gross 
malabsorption  nor  increased energy  expenditure seem  to contribute substantially  to the 
wasting  [291,  328,  330].  TCDD-treated rats also do not appear  to suffer  from  nausea 
[280],  although  recent data regarding neophobic food aversion, induced by  TCDD doses 
not affecting food intake [204, 205],  has raised the possibility  of some visceral  ailments. 
Typically,  a  single lethal TCDD dose leads to a  dramatic reduction  in feeding  and a 
consequent  decline in  body  weight of up to 50%, while a  persistently  stunted growth  and 
decreased feeding  results from  a single high  but sublethal  dose [275,  283, 328, 329].  In 
rats,  the most  studied species,  food intake typically  progressively  decreases during  the first 
few  days after  TCDD exposure, leading to weight  loss,  but the animals do not  usually  show 
a  total  refusal of feeding (an  exception  being  H/W  rats at  doses over  100  μg/kg  [278]).  At 
sublethal doses,  rats generally  increase their  feed intake and start  gaining  weight  in  1–2 
weeks, but  their  body  weight lags behind that  of control  rats [275, 328,  329], and some 
alterations in  feeding rhythm,  feeding behaviour  and feed choice remain  [202, 204, 283, 
377].
An alteration  in  the circadian  pattern  of feeding after a  (lethal) dose of TCDD was first 
noticed in  TCDD-sensitive L–E [279]  and SD rats [58],  and the H/W strain  was later 
found to exhibit  a  slowly  developing  but persistent  increase in  proportional  feed intake 
during  the light hours of the day  after  exposure to a high  sublethal dose (1000 μg/kg) of 
TCDD [276, 277].  A  recent  feeding  and drinking microstructure study  in  L–E and H/W 
rats employing a sublethal (10μg/kg)  and a  lethal (100 μg/kg) and two sublethal  doses 
(100  and 1000  μg/kg),  respectively, partly  confirmed previous findings [202].  In  L–E rats, 
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the lethal  dose of TCDD induced a  precipitous drop in  feed intake accompanied by  a 
reduced meal size in  the evening, night  and morning, but not in  the daytime,  and eating 
suppression  peaked during the morning, while at the sublethal dose only  a  slight decrease 
in  the number  of meals during  the daytime was observed.  In contrast,  in  H/W rats the 
hypophagia  remained moderate  at  both doses, stemming from  reduced meal frequency, 
and the main  effects were seen  during  the constant  light  or  dark  phases. In conclusion, the 
AHR may  play  a  modulating role in  the circadian  rhythms of feeding, but  different 
regulatory pathways seem to underlie the feeding responses in L–E and H/W rats [203].
Feeding (as many  other  phenomena) has circadian rhythms controlled by  clock genes 
belonging to the bHLH/PAS protein  superfamily  [174], and the neuronal circuits of feed 
intake regulation and circadian  rhythmicity  are closely  connected (see 2.4.6).  Expression 
of the AHR protein  fluctuates in several tissues of mice and rats in  the course of the day 
[242,  309],  and although  the physiological  role  of the AHR in  circadian rhythms is still 
debatable, some findings support a  role for  the clock genes Per1  and Per2  in  the 
modulation  of AHR-mediated responses to TCDD in  different  organs in vivo [242, 295, 
296]  and in vitro  [96,  428].  Both  genes are strongly  expressed in  the rat  suprachiasmatic 
nucleus (SCN; the master  circadian  clock)  [332], and a  low  dose of TCDD has been  shown 
to induce a rapid and transient  phase shift  in the circadian  expression of mouse PER1 
protein  in  the SCN and liver  [207].  Another  system  that bears on  the circadian  feeding 
rhythms and food intake is the histaminergic tone in  the hypothalamus [118].  Accordingly, 
a  slight increase was recorded in  histamine concentrations in  the whole hypothalamus of 
L–E rats at 28  h  after  a  low  but  generally  lethal  TCDD dose of 50  μg/kg  [369], and in  the 
median  eminence of outbred Long–Evans rats at  25  h after a  high  lethal  (1000 μg/kg) 
dose [376]. These changes, however, were minor  and do not  support  the role of histamine 
as a key mediator in TCDD-induced hypophagia.
Exposure of rats and mice to TCDD not only  reduces total feed consumption  and alters 
the feeding  rhythmicity,  but  also results in a  peculiar, rapidly-emerging  and long-lasting 
aversion  to novel  food items,  originally  observed as a  neophobic avoidance of a  tasty  food 
item  (chocolate) in  TCDD-exposed rats [377]. Later, the neophobic  food aversion was 
found not  to be strictly  confined to any  specific  food type,  although  exceptionally 
pronounced to chocolate, but requiring temporal  proximity  to the TCDD exposure [204], 
and findings from  Ahr-deficient  and wild-type mice implied the involvement  of the AHR 
[205].  Intriguingly,  the latter  study  also showed the similarity  of the ED50  values for  novel 
food item  aversion  to those for  CYP1A1  induction  in  the liver, suggesting  the aversion  to be 
a  means to restrict exposure to potentially  toxic dietary  substances causing  the hepatic 
induction of xenobiotic-metabolising  enzymes. The relationship between  the aversion 
reaction and the wasting syndrome is,  however,  unclear.  Mechanistically, the novel  food 
avoidance could be explainable by  taste (gustatory)  neophobia  (innate fear  of new  foods) 
or  conditioned taste aversion  (CTA; learned aversion  to a novel taste associated with 
transient visceral  illness);  see 2.4.7  for  discussion  of the neurophysiology  of these 
reactions.
Experiments combing  TCDD with  other food-intake and body  weight  change-inducing 
treatments have yielded variable results,  while the animals generally  defend their  lowered 
body  weight  level  against  feeding  challenges [275, 277,  328-330]. The type of diet affects 
the severity  of the body  weight loss and lethality, and fat appears to be an  unfavourable 
source of energy  after  TCDD exposure [246, 247, 372,  377]. However, an  unexpected 
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outcome regarding  the effect of diet  appeared in a  study  in  female TCDD-sensitive mice, 
which  on  a  high-fat  diet  significantly  increased their  weight  gain  after  biweekly  exposure 
to 100 μg/kg TCDD for  a  period of 8  weeks [435].  In  comparison, in  a  recent  study 
employing  a  high-fat  and low-fibre (Western) diet  but no dioxin  exposure, TCDD-
susceptible mice with  a  high-TCDD-affinity  AHR gained significantly  more weight and 
more fat  tissue (in  absolute terms)  than  congenic  10-fold more TCDD-resistant mice with 
a low-affinity AHR. The regular diet had no significant differential effects [173].
2.4.3 WEIGHT SET POINT AND WASTING
To explain  the apparent  energy  homeostasis,  a  theoretical “set-point”  towards which  body 
mass (or  its correlate) is regulated was proposed [129,  344], contested by  a  ‘‘settling-
point”  hypothesis contending  that  body  weight  and adiposity  simply  represent a  freely 
fluctuating settled level  formed by  energy  intake (inflow) and expenditure (outflow) [411]. 
Later,  a  refined, simulation-based “general  model  of intake regulation”  akin  to the 
settling-point hypothesis was put  forward to specifically  address human  behaviour  and 
disposition to obesity  [62],  and finally  a  “dual intervention  point model”  was recently 
devised,  combining the active regulation of the set-point  model,  outside of the upper  and 
lower  intervention  (set-) points, with  the settling-point  model of passive regulation 
operating  in  between  them  [344]. Notably,  the  last  two models are abstract  and address 
weight  regulation,  especially  obesity,  mainly  in humans.  In contrast, a  number  of studies 
in  laboratory  animals (and in  humans in  certain  settings)  have demonstrated that  body 
weight  seems indeed to be defended [169,  344],  and this system  can  be actively  regulated 
and dynamically adjusted [48, 237].
There is compelling evidence of the avidity  of dioxin-treated rats to defend their 
lowered body  weight  level (see 2.4.2) and react  to lesions of the hypothalamic nuclei (see 
2.4.6),  in  a  way  consistent with  the maladjustment  of a  pursued body  weight  set-point. In 
addition,  rats made diabetic  (showing  simultaneous hyperphagia  and underweight) before 
TCDD administration  continued to exhibit  increased eating  relative to non-diabetic 
control  rats, suggesting  that  reduction  of feeding  is a  secondary  rather than the primary 
effect of TCDD [284]. 
The regulated primary  variable for  a  weight set point  is,  however, still elusive.  Initially, 
blood steroids were suggested as the principal correlate of body  weight [129], and this idea 
was later  modified by  hypothesising that  the concentration  of hypothalamic corticotropin 
releasing factor  (CRF) would serve this function,  so that a  decrease in  this concentration 
would stimulate food intake [48]. On  the other  hand,  studies in  seasonal mammals have 
pinpointed thyroid hormone as a  cause of the rhythmic  alterations in  energy  balance [79], 
the ultimate regulator  in  this case conceivably  being  the thyrotropin-releasing hormone 
neurons [197].  Finally,  a  structural  basis for  the set point might be formed by  synaptic or 
neuronal  plasticity  with  a  perpetual struggle between orexigenic and anorexigenic  tones 
[4, 71].  Intriguingly,  plasma ACTH and corticosterone levels are  elevated in rats treated 
with  TCDD [25, 236], suggestive of increased hypothalamic  CRF. One study  also detected 
increased mRNA  levels of CRF in  the hypothalamic PVN (a  critical  site for  the effects of 
CRF on  food intake [185]) and ARC nuclei 7  and 14  days after  TCDD administration, while 
there was a transient reduction in CRF expression in some related nuclei at 2 days [236].
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2.4.4 PERIPHERAL ADIPOSITY AND SATIETY SIGNALS
The long-term  adjustment  of body  weight  and the regulation  of energy  balance in 
mammals is based on  keeping the body  fat  stores constant  with  the aid of two adiposity 
signals,  leptin  and insulin  (Figure 5); for  recent  reviews, see e.g. [241, 319, 417].  Leptin, 
originating  from  adipocytes, and insulin, produced by  the pancreas, convey  information 
on  body  adiposity  to the CNS [16, 17], while  insulin  also has a  second,  equally  important 
and partly  overlapping role in  constant  regulation  of plasma  glucose [103, 194]. Depletion 
of leptin  or  insulin,  or  their receptors,  generally  results in  increased food intake and 
obesity  mediated by  the brain  [103,  319]; type 1  diabetes represents a pathological state of 
insulin  depletion  leading  to weight  loss due to severely  impaired glucose utilisation. 
Administration  of exogenous leptin or  insulin  (at low  doses not inducing  hypoglycaemia) 
brings about  marked reductions in  food intake and body  weight  [113,  120, 191,  317], but 
after  about two weeks of leptin  administration  food intake normalises while body  weight 
remains repressed [120,  317,  318].  Resistance to leptin and insulin  occurs in obesity  and 
type 2 diabetes [87, 120, 239], as well as in inflammation in the CNS [289, 359].
At lethal doses, TCDD reduces circulating  insulin  levels in  rats most likely  through 
diminished feed intake [108,  109],  while at  a  sublethal dose it seems to directly  reduce 
insulin  secretion  [108].  Impairment  of glucose-stimulated insulin  secretion  was also 
reported in  islets isolated from  rats treated with  a  low  (1μg/kg; no effect  on feed intake) 
TCDD dose [251]. On  the other  hand, various findings imply  that TCDD improves insulin 
sensitivity  (see also 2.4.4) at  the whole organism  level,  at  least  in rats and mice [213], 
prompting further  research regarding  the transport  of insulin  from  the blood to the CNS 
and the central  insulin action  in  TCDD-exposed animals in  relation to wasting  syndrome 
pathogenesis. There is also a  paucity  of data  on  the possible influence of dioxin  on leptin. 
A  small-scale experiment  with  TCDD doses affecting  feed intake showed an  initially 
elevated plasma leptin  concentration  (measured with  mouse leptin  antibody) on  day  1 
after  TCDD exposure, but  then an  identical downhill  course in  both  TCDD-treated L-E rats 
and their  pair-fed controls [371].  In  comparison,  unchanged plasma leptin  levels were 
reported 24 h after a low (1μg/kg) dose of TCDD in SD rats [251].
In  lieu  of the long-term  adiposity  signals, there are a  number  of messengers that 
suppress appetite in  response to food and energy  ingestion  and act  as satiation  signals 
(Figure 5) [417].  These small  peptides are produced in  the intestine (e.g.  cholecystokinin 
[CCK], glucagon, oxyntomodulin,  peptide YY, enterostatin) or  in the pancreas (amylin  and 
pancreatic  polypeptide),  and most of them  act  primarily  or  partially  via  vagal afferent 
fibres [20, 39, 53, 76,  164, 183,  313]. Traditionally, the satiation  signals were  considered to 
be short  acting, but at least some of them  seem  to have also a  role in  longer-term  energy 
balance regulation  and interact  both  with  each  other  and with  insulin  and leptin  [24,  218, 
419]. In  regard to TCDD and energy  ingestion,  a  long-lasting change in  consummatory 
behaviour,  interpreted as augmented sensitivity  to post-ingestive satiation,  was detected 
some 2  weeks after  exposure to a  high (1000  μg/kg) but  sublethal dose of TCDD in  H/W 
rats [276,  282]. However, the feeding  response to peripherally  administered CCK 
concomitantly  remained unaffected [277,  282],  and vagotomy  had an  additive,  not an 
alleviating effect on feed intake and body weight in TCDD-treated L-E or H/W rats [368].
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2.4.5 PERIPHERAL SIGNALS INDUCING FOOD INTAKE
Peripheral  hormonal signals directly  inducing food intake are conspicuously  few  (ghrelin 
being the sole generally  accepted example),  but  several  neurons in the CNS and 
peripherally  are capable of sensing the levels of glucose,  fatty  acids and amino acids 
(Figure 5) [194,  319, 360].  In addition, the brain  indirectly  receives information  on  (at 
least)  peripheral  glucose levels through  the vagus nerve, insulin  and ghrelin  [194, 342, 
360, 426].  Direct nutrient sensing of glucose,  in  particular,  is important in  maintaining 
the short-term  energy  stores at  physiological  levels and also intricately  intertwined with 
the long-term  regulation  of energy  balance.  As an  example of this constant regulation,  a 
decrease in  blood glucose below  the euglygemic level triggers an  immediate release of 
glucagon  and elicitation  of feeding [194, 360],  although this glucostatic/glucoprivic 
feeding initiation  is generally  assumed to come into play  in  non-physiological,  acute 
energy  depletion  states [77]. Ghrelin  seems to act both  as an  “acute”  hunger  signal and as 
a  longer-term  augmenting  factor  of feeding  [24, 71,  154, 294,  419].  It  is produced both 
peripherally  and centrally  in  the ARC and appears to increase food intake by  direct  CNS 
receptor  (growth  hormone secretagogue receptor; Gshr)  stimulation and/or  through the 
vagus nerve,  with  the possible involvement  of hypothalamic de novo  synthesis [24,  61,  71, 
158, 182, 294, 419].
No studies have hitherto addressed the possible role of ghrelin  in  the wasting 
syndrome, but glucose-depletion  (glucoprivic) challenges have been  imposed on  TCDD-
treated rats.  A  high  but  sublethal dose of TCDD (1000 μg/kg) in H/W  rats rapidly 
abolished the normal feeding response to glucoprivation  induced by  2-deoxy-glucose 
(2DG) or  by  a high dose of insulin  [283], and the response seemed to be persistent  [277]. 
Thus, the inability  of TCDD-exposed rats to respond by  eating  to an  acute energetic  crisis 
may  be the key  reason for  their  sensitivity  to insulin  lethality  [109, 277,  283]. In 
comparison, in  mice a low  TCDD dose (not affecting  body  weight  gain) induced a  swift and 
long-lasting reduction  (20–30%) in  glucose transport  to the brain  and a  comparable 
reduction in  GLUT1  (Slc2a1 gene) protein  expression  [214]. As noted earlier,  vagotomy  did 
not markedly  modify  the effect  of TCDD on  feed intake or  body  weight  [368], arguing 
against a  critical role for  vagal signals in  the wasting  syndrome. However, vagotomy  had 
an  additive  diminishing impact on  body  weight,  resembling  that  of a  DMH lesion  (see 
2.4.6).
2.4.6 THE HYPOTHALAMUS IN FOOD INTAKE REGULATION
The hypothalamus, particularly  the ARC,  as well as the ventromedial hypothalamic 
nucleus (VMH), dorsomedial hypothalamic nucleus (DMH),  LHA  and PVN are believed to 
play  a  pivotal role  in  the integration  of feeding-regulatory  signals, especially  insulin  and 
leptin  [191, 194,  248] (Figure 5).  As a basic  mechanism, insulin  and leptin  modulate in 
tight  integration  the two populations of neurons acting as the cardinal regulators of energy 
balance in  the ARC [87,  194, 319]: the food intake increasing  agouti related protein/
neuropeptide Y (AgRP/NPY) neurons reduce their  activity  and neurotransmitter 
expression  following leptin and insulin  stimulation, whereas the anorexigenic  neurons, 
expressing  pro-opiomelanocortin/cocaine- and amphetamine-regulated transcript 
(POMC/CART),  function  in  the opposite way.  However,  the organisation  of the system, 
even  in  the ARC,  is far more complex,  as exemplified by  the differing  electrophysiological 
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effects of insulin  and leptin  [133, 241, 319], constant  suppression  of POMC/CART  neurons 
by  AgRP/NPY  neurons [95, 228],  the considerable regional  variability  in  leptin 
responsiveness of POMC neurons [325], and the non-monotonous effects of exogenous 
leptin  (see 2.4.4). The ARC also receives and projects various inhibitory  and excitatory 
contacts to other  areas in  the hypothalamus [4,  241, 319], and the synaptic  or  neuronal 
plasticity  in- and outside the ARC (also shown to be modulated by  ghrelin  and leptin) is 
even  suggested to be a  structural basis for  the body  weight set-point  [4,  71].  Notably, 
plasma nutrient  levels, at least  glucose and fatty  acids, also influence the activity  of 
orexigenic and anorexigenic neurons in the ARC [195, 290, 319].
Beyond the ARC,  AgRP/NPY and POMC/CART neurons innervate the VMH, PVN,  LHA 
and DMH,  as well as several other  hypothalamic and extra-hypothalamic nuclei, e.g.  the 
parabrachial nucleus (PBN) [4,  36].  POMC/CART  neurons even  extend their  connections 
to the brainstem,  including  the nucleus  tractus  solitarii (NTS) [339].  Of the hypothalamic 
nuclei,  the “satiety  centre”  VMH,  restricting  eating  and body  weight gain, is assumed to 
have an  independent  role in  the promotion  of food intake,  responding  to at  least  glucose 
and leptin  [249, 319],  while the anorexigenic PVN and the orexigenic LHA are important 
relay  sites of information  for  autonomic and neuroendocrine effects and eating, with 
afferent connections to the brainstem. The LHA  also communicates with  cortical neurons 
and integrates energy  balance and reward circuits [87,  241, 249]. The orexigenic DMH is 
innervated by  NPY/AgRP-positive fibres from  the ARC, and,  akin  to the VMH, 
autonomously  adjusts the energy  balance in  response to glucose and leptin  [19,  180,  436]. 
The VMH–SCN connection  has recently  been shown  to affect  experimental  food 
anticipatory  activity,  attesting to the role of the VMH in  the link  between  circadian 
rhythms and eating regulation [5].
Studies combining TCDD administration  with  targeted hypothalamic lesions have 
revealed some hypothalamic nuclei to be  connected with  the wasting syndrome,  and offer 
support  to the notion  that  TCDD somehow  adjusts the pursued body  weight level. A  VMH 
lesion inducing hyperphagia  and metabolic obesity  aggravated TCDD-induced wasting 
syndrome in  both  TCDD-sensitive L–E and TCDD-resistant  H/W  rats when it  preceded 
TCDD treatment [373],  while a  lesion of the orexigenic  DMH induced an  additive 
reduction of food intake with  TCDD in  H/W rats [375]. Respectively, findings after  a 
lesion of the anorexigenic  PVN (causing an  increase in  food intake and body  weight, 
especially  with a  palatable diet) were slightly  different  from  the VMH lesion  [374].  The 
PVN lesion  led to an increased feed intake and overweight  in  comparison to the sham-
operated controls only  after the rats were offered palatable chocolate in  addition  to the 
standard diet.  After  TCDD administration,  the lesioned rats reduced their  feed 
consumption more than  the sham-operated counterparts,  so that  3  weeks after TCDD 
exposure the body  weights of the lesioned and sham  groups were indistinguishable.  In 
addition,  the TCDD-exposed rats clearly  reduced their  energy  intake and changed their 
dietary  composition,  especially  by  reducing  chocolate (fat and carbohydrate)  intake, 
suggesting  an  aversion  to energy-rich  food and an  altered taste preference. Intriguingly, 
this and the exaggerated anorexia  after  a  PVN lesion might  be mechanistically  explainable 
by  an  effect  of TCDD on a system  or  centre regulating body  weight  “before” the PVN, 
resulting  in  a  similar  set point in  both  lesioned and sham-operated animals.  Notably, the 
PVN and DMH lesion  experiments were conducted with  H/W  rats employing  high  but 
sub-lethal TCDD doses of 1000 μg/kg.
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2.4.7 BRAINSTEM, REWARD CIRCUITRY AND FOOD AVERSION
The caudal hindbrain  is the main  site receiving  information  from  peripheral  energy 
metabolism, chiefly  by  way  of the vagal afferent  fibres (Figure 5).  It  is particularly  involved 
in  the control of meal size via  signals arising  from  the mouth  and gastrointestinal  tract, 
and the NTS functions as an  important  integrator  in  energy  balance regulation  [24, 95, 
112].  Caudal  brainstem  circuits also initiate  glucoprivic  feeding,  contain  systems for 
satiating signal and leptin  interaction, and have multiple afferent  connections to the 
hypothalamus [112,  310].  As to the impacts of TCDD on energy  homeostasis,  the hindbrain 
has not  been  addressed, but the prominent  effects of TCDD on  glucoprivic feeding,  meal 
size and aversion  to novel food items encourage further  study.  In  addition,  the caudal 
brainstem  has been  suggested to be an  important target for  the anorexigenic  action  of 
leptin  in  rats [113], possibly  explained by  the leptin-induced inhibition  of serotonin 
synthesis and release from  brainstem  neurons, as shown  in  mice [424,  425].  This 
paradoxical effect  of a  reduced serotonin  (a  generally  anorexigenic transmitter)  level  in  the 
hypothalamus is thought to be mediated by  specific serotonin HTR1A  autoreceptors in the 
ARC (see 2.4.8).
The complex  reward-based regulation  of eating  involves interactions between  various 
CNS  centres relying,  for  example, on  dopamine (see  2.4.8.) and on  opioid and cannabinoid 
systems in  signal transmission  [333,  355, 422]. The midbrain mesolimbic dopaminergic 
system  contains a  set  of ventral tegmental area  (VTA)  neurons that  innervate the striatum, 
amygdala  and prefrontal cortex  [249,  333],  and leptin  and insulin  act  directly  on  VTA 
neurons,  reducing dopamine release and diminishing  food seeking  and intake [87], 
whereas food restriction  and ghrelin induce an  opposite effect  [191,  333] (Figure 5).  LHA 
orexin  neurons project  to the VTA,  and stimulation  of the LHA  strongly  promotes food 
seeking  [87, 249,  333]. A subconscious ‘‘liking  reaction”  to food can  be elicited by 
hindbrain  neural circuits, and seems to be related to the  striatal  nucleus accumbens (NAc) 
and ventral pallidum  [333],  while the NAc  has an  inhibitory  feed-back  loop with  melanin 
concentrating  hormone (MCH) neurons in  the LHA  [320,  347].  The aversive reactions to 
food (see 2.4.2),  taste neophobia and CTA,  are closely  correlated and are both  mediated at 
the cognitive level by  the basolateral amygdala  (BLA) and insular  cortex  (IC) [211,  307, 
312]. However,  in  CTA  the required malaise stimulus is transmitted via  the vagus nerve or 
through  the area  postrema  to the NTS,  and from  there to the PBN, before reaching  the 
BLA  and IC [253].  Loss of GABAerigic  (γ-aminobutyric acid; the main  inhibitory 
neurotransmitter  in  the CNS) inhibition  of PBN (see 2.4.8) even  leads to anorexia  and 
starvation in mice, possibly due to nausea [420].
The reward circuitry  does not seem  to have a  direct critical  role  in  the wasting 
syndrome, but  the available mechanistic data  are very  scant.  Increased neuronal activation 
was detected in  several hypothalamic  nuclei,  the central amygdala  and bed nucleus of the 
stria  terminalis (BST) some days after  TCDD (50 μg/kg) administration  to rats [57], and 
later  the same group reported an increase in   methionine–encephalin  immunoreactivity  in 
various forebrain nuclei, such  as the central  amygdala,  PVN and BST  2  weeks after  similar 
TCDD treatment [56].  However,  the authors suggest  the latter  to be a  compensatory 
reaction to body  weight loss and hypophagia.  As an  indirect finding  regarding TCDD and 
food reward, H/W  rats treated with  a  high  dose of TCDD 3  months earlier  exhibited a 
blunted reaction to the opioid antagonist  naloxone,  which  reduced the 24-h fast-induced 
feeding in control animals [277].
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2.4.8 THE NEUROTRANSMITTERS OF FEEDING REGULATION
In  hypothalamus, the strongly  orexigenic NPY  signals through several  (redundant) 
receptor  types [161,  302],  and the LHA  seems to be the principal site of its action,  even 
though  it  also inhibits neuronal firing  in  the PVN and VMH [4, 54].  The orexigenic effect 
through  the LHA  is generally  believed to be mediated by  MCH, with  a  shorter-term 
influence of orexins (hypocretins),  although  the exact  mechanism  of NPY-induced 
stimulation of MCH  secretion  is unclear  [36, 117]. Another layer  of complexity  is 
exemplified in neuropeptide Y receptor Y5  (Npy5r)  knock-out  studies, in which 
unexpected obesity  has resulted despite inhibition  of the NPY system  inhibition, probably 
due to a  compensatory  change in  POMC/AgRP gene expression  [130].  The anorexigenic 
melanocortin  system  is based on melanocyte-stimulating  hormone (α-MSH), produced 
from  POMC  in  POMC/CART neurons and secreted together  with  CART [4, 71]. The 
principal  second order  nucleus in melanocortin  signaling  is the PVN,  which  contains high 
levels of melanocortin receptors 3  and 4  (MC3R,  MC4R) stimulated by  α-MSH [4].  It  also 
appears to be an important convergence point  of anorexigenic and orexigenic signalling, 
since AgRP, the second product  of AgRP/NPY neurons,  is an  antagonist of 
melanonocortin receptors, and CRF exerts its anorexic effect in the PVN.
The classical monoamine neurotransmitters serotonin (5-hydroxytryptamine, 5-HT), 
noradrenaline and dopamine, as well  as histamine (see 2.4.2.), also take part in  the control 
of energy  balance. Serotonin  generally  has a suppressive effect  on  food intake and body 
weight, for  example in  the PVN,  VMH  and DMH, mainly  acting through  1B (HTR1B) and 
possibly  1C (HTR1C) receptors [301],  while autoreceptor  HTR1A  mediates hyperphagia 
[60]. It has even  been  proposed that leptin  may  exert its action  on  food intake by 
inhibiting the production of serotonin  in  brainstem  neurons (see  2.4.7.). This would then 
curtail the appetite  through  reduced HTR1A activity  in  the ARC, leading to increased 
POMC expression and decreased NPY  and AgRP expression  [424,  425].  Noradrenaline 
may  have dual effects on  food intake: in the PVN, activation  of α2  receptors stimulates 
feeding,  whereas α1  agonists suppress it  [301]. Dopamine (DA)  appears to be more 
influenced by  food intake rather  than  influencing it  [301]. Intriguingly, however,  mice that 
lack  dopamine (DA), exhibit fatal hypophagia  as part  of a  generalised hypoactivity  and 
respond differently  to the restoration  of DA  activity  in  individual nuclei,  depending  on the 
targeted area  [355]. Restoration  of DA  production  within  the caudate putamen  restores 
feeding and nest-building  behaviour,  whereas restoration  of DA  production  in the NAc 
restores exploratory  behaviour. Intervention  in  either  region  restores the preference for 
sucrose or  a palatable diet  without  fully  rescuing coordination  or  the initiation  of 
movement, the classical alterations in dopamine deficiency.
Few  studies have directly  addressed the effect of TCDD on  hypothalamic 
neuropeptides,  dopamine or  noradrenaline, while the serotonergic system  has received 
considerable attention. A  sublethal TCDD dose (15  μg/kg)  in SD rats brought  about  an 
increased expression  of Npy,  Pomc and CART  prepropeptide (Cartpt)  mRNA  in  the ARC 
at  a  6  days, and in  the LHA,  pro-melanin-concentrating hormone (Pmch)  expression  was 
also elevated [86]. In  line with  these findings,  a  dose (50 μg/kg) close to the LD50  value of 
the same strain  of rat increased POMC mRNA  levels in  the ARC at 7  and 14  days; at the 
latter  time-point,  a  significant increase was also found at  lower  doses [236].  Serotonin 
turnover  was found to be uniformly  accelerated after  a  single dose of 50  μg/kg  in  L-E 
(lethal) but  not  in  H/W  rats (sublethal) in  several dissected brain  areas,  including  the 
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hypothalamus [387]. However, the reason for  the increased turnover was shown to be an 
increased level of plasma-free tryptophan  [389], and it  does not appear  to be causally 
related to the wasting syndrome, because specific depletion  of brain  serotonin did not 
affect  the TCDD-induced reduction  in  body  weight  [346]. In  support  of the reasoning 
above on  the role of monoamines in  TCDD toxicity,  intervention  with  dopamine 
antagonists,  an  α-adrenoceptor  blocker  or  a  serotonin  synthesis inhibitor  did not 
modulate TCDD-induced wasting  syndrome in  L-E rats [279].  In conclusion, there is thus 
limited evidence for  the direct interference of TCDD in the action  of regulatory 
neuropeptides or  monoamine neurotransmitters.  However,  more information  is needed 
regarding  the neuropeptides,  especially  on  the early  stages of dioxin  intoxication,  and 
possible changes at the level of single nuclei.
Recent  findings underline the importance of GABAergic and glutamatergic (the 
dominant excitatory  transmitter  in  hypothalamic  neuroendocrine regulation) 
transmission  in  the regulation of feeding,  especially  in  the LHA. Glutamate elicits an 
intense feeding  response in  satiated rats when injected into the LHA [228],  and is 
currently  considered as a  major  orexingenic  factor, functioning  especially  through  the 
various NMDA receptor  subtypes [347].  In  contrast,  GABA  appears to function  in  the LHA 
as a  mediator  of satiety  via  GABAA receptors [347,  379],  while the loss of GABAergic 
transmission  of AgRP/NPY  neurons to the PBN leads to the activation  of postsynaptic 
neurons and starvation,  which is proposed to be related to the activation of circuits that 
normally  promote nausea-induced anorexia  [420, 421]. GABA  is also orexigenic by  way  of 
its inhibitory  action  on  POMC/CART cells in  the ARC,  where both GABAA and GABAB 
receptors have been demonstrated [228]. 
To combine the actions of NPY, glutamate and GABA, Stanley  et  al. [347] proposed the 
LHA  to be the major  integrator  of moment-to-moment feeding, which  to a  large extent 
reflects the balance of glutamatergic and GABAergic inputs to LHA  neurons,  and that this 
balance modulates and is modulated by  peptidergic actions.  There is evidence from 
prenatally  exposed animals that dioxins may  affect  GABAergic and glutamatergic 
neurotransmission in  the CNS. For  example,  prenatal  TCDD exposure in  rats postnatally 
induced glutamate receptor  subunit mRNA  alterations in the cortex  and hippocampus 
[138, 160],  while in  mice it  was found to compromise the differentiation  of GABAergic 
neurons in  the ventral telencephalon  [107]. However,  hardly  anything  is known of the 
possible modulation of GABAergic  or  glutamatergic neurotransmission by  dioxins in  adult 
animals.
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Figure 5. A highly simplified, schematic representation of some major centres in the CNS involved 
in food intake regulation and in the reception of peripheral signals mediating information related to 
adiposity, nutrients and satiation. The CNS nuclei and signals are designated anorexigenic 
(amber), orexigenic (light green) or integrating (blue) according to their primary role based, for 
example, on lesion experiments. Directly or indirectly excitatory connections are depicted by bright 
green links and directly or indirectly inhibitory connections by bright red links. PVN paraventricular 
nucleus, DMH dorsomedial hypothalamus, VMH ventromedial hypothalamic nucleus, LHA lateral 
hypothalamic area, VTA ventral tegmental area, ARC arcuate nucleus, NTS nucleus tractus 
solitarii, PBN parabrachial nucleus, NAc nucleus accumbens. Modified from [213, 241, 319].
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2.5 QUANTITATIVE REAL-TIME RT-PCR IN GENE EXPRESSION 
ANALYSIS
Quantitative real-time RT-PCR is the most  cost-effective and sensitive method to chart 
TCDD-induced gene expression  alterations at various time points after  exposure and a 
with  limited amount  of RNA.  However, this methodology  is not  without  challenges: The 
precision  of the cDNA  synthesis step is a  major determinant  of reliable expression 
analysis,  and toxicological  studies involving  TCDD have an  additional difficulty  in  finding 
stable reference genes among the extensive and divergent  expression  changes induced by 
AHR activation.  The quantitative real-time RT-PCR technique is briefly  reviewed here, 
since two studies of this thesis assessed the reproducibility  of the reverse transcription 
step, the fidelity  of the RT  enzymes and the applicability  of some control genes for  dioxin 
studies.
2.5.1 DEVELOPMENT OF RT-qPCR
Two-step reverse transcription quantitative real-time PCR (RT-qPCR) is a  technique to 
measure the abundance of mRNA  transcripts (gene expression)  by  first  reverse 
transcribing  extracted RNA  to cDNA  in  one reaction,  and then  quantifying  the cDNA 
stretch  corresponding to the mRNA of interest  in  a  separate quantitative real-time PCR 
(qPCR) reaction [43,  44, 186]. The first step,  reverse transcription (RT),  has been  used in 
molecular  biology  from  the beginning of the 1970s [345], and the first  studies (conducted 
at  the end of the 1980s) that used reverse transcription  and PCR to measure mRNA 
employed an RT step that  was similar to the one used today.  However,  the PCR step was 
much  different, as it  relied on conventional end-point  PCR and densitometric  analysis of 
ethidium  bromide (EtBR)-stained gels or radioactively  labelled primers to quantify  the 
amplified product (amplicon) [55, 304, 305, 396].
Using  end-point PCR for  quantitative analysis is inherently  problematic [42],  and the 
use of internal (reverse transcribed together  with  the target RNA) heterologous reference 
(housekeeping) genes – as was often done – did not  amend this, although  it  allowed the 
normalisation  and comparison  of the measured raw  target  gene values.  An  alternative 
method, “competitive PCR”,  offered a means to greatly  improve the reliability  of the 
quantification  by  using  an  added synthetic  or  cross-species nucleic acid standard that 
competed for  the same primers as the target sequence in the same PCR reaction  [334]. 
After  PCR, the amplicon  of interest  and the standard amplicon  were separated in  an 
agarose gel  based on  their  lengths,  or  according to sequence differences using  other 
methods, and quantified as above.  Furthermore, the synthetic nucleic  acid standards could 
be also made of RNA  (and can  thus be referred to as internal for  the RT reaction),  enabling 
the normalisation  of both  RT  and PCR reactions and a  simple (in  principle) way  of 
multiplexing [396].  Incidentally, competitive PCR, with  various quantification  protocols 
and strategies, has remained  and developed over  the years as an  alternative to qPCR, 
especially  for  mRNA quantification,  as it  is claimed to be exceedingly  accurate [433], while 
not as adaptable as RT-qPCR.
Real-time monitoring  of the PCR reaction  for  quantification  of the initial  template copy 
number  was first  suggested and developed by  Higuchi et al. using  EtBR [131, 132].  Some 
three to four  years later,  in  the mid-1990s, the technique was refined to use a  threshold 
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cycle  Cq (Ct)  for  quantification and dual-labelled fluorogenic hybridisation  probes as 
reporters [106,  126],  and the first  dedicated rapid cycle qPCR instrument was described 
[413]. In  addition, another  system  of fluorogenic  probes and the currently  most  employed 
dsDNA-specific  dye (SYBR Green  I)  were exploited as reporters, and melting  curves 
suggested as a  means to measure the specificity  of the amplification  [412]. Finally, in  the 
following  10  years,  the qPCR technique established itself as the most  powerful and agile 
tool  for  quantitative nucleic  acids analysis [186, 398]. It  has shown  burgeoning  growth  in 
the last  few  years,  attested for  example by  the exponential  increase in the annual PubMed 
citations retrieved with  the keyword “qPCR”, and by  the large number of reviews dealing 
with  the subject  [45,  176, 186,  244, 361]. There is also an  active and opulent  website 
dealing  with various aspects of RT-qPCR (Gene-Quantification.info WWW [URL: http://
gene-quantification.info]).
2.5.2 HYBRIDISATION-BASED mRNA ANALYSIS TECHNIQUES
A  number  of hybridisation  techniques are capable of directly  detecting  and quantifying 
mRNA. These methods offer the definitive advantage over RT-qPCR of not requiring the 
poorly  controllable RT step,  although they  have a  number  of their  own  shortcomings. 
Below, the four most widely used of these methods are discussed in collation to RT-qPCR.
The first  widely  employed technique to directly  detect specific mRNA  species was 
Northern  blotting,  in  which  RNA is separated by  gel electrophoresis,  transferred to a 
membrane and identified by  hybridisation  with  a  labelled (often the radioisotope 32P) 
nucleic  acid probe [10,  11].  This method is still employed in  expression analysis [15],  and 
quite  useful in  the study  of RNA  degradation  and transcript size [398]. The RNase 
protection  assay  is another  method used to quantify  and characterise RNA  species. In  this 
technique, isolated RNA  is first  hybridised with isotopically-labelled antisense RNA 
probe(s), protecting  target sequence–probe hybrids from  digestion  in  the following  single 
strand-specific  RNase treatment. The remaining  target  and labelled probe nucleotides are 
finally  separated in  a  polyacrylamide gel  and visualised by  autoradiography  [49, 198].  The 
RNase protection  assay  is currently  most  often  used in  studies involving analysis of the 
RNA  production rate and decay  or mapping  of post-transcriptional  RNA modification  [8, 
343], while it  is generally  less often  employed for  simple expression  measurements. In 
contrast  to Northern  blotting,  it offers the possibility  of multiplexing  (by  adjusting  probe 
lengths),  and is more sensitive and accurate in  low  abundance mRNA  quantification. 
However,  both  of these methods are technically  complicated and multiphase, not as 
sensitive as RT-qPCR, not  very  straightforward to multiplex  or  extend, and are also 
hampered by quantification and normalisation difficulties.
A  new  hybridisation-based method, the nCounter  gene expression  system, using 
colour-coded probe pairs has been developed by  NanoString  Technologies [100].  This 
combination  of capturing and reporting  probes with colour-coded tags of several 
fluorophores provides a  unique detection  signal for  up to several hundreds of mRNA 
species at  the same time. The nCounter  is claimed to be similar  in  sensitivity  and accuracy 
to RT-PCR, and, being  a  streamlined commercial assay  system, is uncomplicated to use 
(NanoString  Technologies WWW [URL: http://nanostring.com]. Retrieved November 
2012).  On  the other  hand, the system  is generally  intended for  the analysis of more than 
one hundred mRNA  transcripts at a  time with  several  pre-designed gene sets.  Moreover, 
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although  the desired mRNA  targets (assuming their  sequence is known)  can  be freely 
selected,  the actual colour-coded probe sets are designed and synthesised by  NanoString. 
The cost  and time needed for  the probe synthesis and the expense of the hybridisation  and 
imaging  unit  thus make the system  less well suited for  rapid and affordable analysis of 
variable mRNA transcripts.
In situ hybridisation  (ISH) enables the combined accurate anatomical localisation  and 
detection  or  quantification  of specific nucleic  acid sequences either  in  tissue sections or  in 
whole cell  preparations, based on  the complementary  binding  of a  nucleotide probe (with 
a  radioactive or  non-radioactive label) to a specific target sequence of DNA or  RNA inside 
cells [226, 399].  Accordingly, the ISH  has become one of the principal techniques in 
neurophysiological and -anatomical  research [86, 152,  200], and has evolved,  with  the 
advent of fluorescent and microscopic techniques,  into a  group of methods with  abilities to 
provide extremely  detailed chromosomal analysis and subcellular  localisation  of single 
mRNA  molecules [206,  399].  The major  drawbacks of the IHS and FISH (fluorescence in 
situ  hybridisation) techniques are the difficult  RNA  probe synthesis, the inability  to use 
more than a  few  probes simultaneously  on one tissue section and the relatively  poor 
reproducibility  between  experiments.  These obstacles can  be surmounted, as 
demonstrated by  the genome-wide mouse brain  expression  atlas constructed using  ISH 
with  non-isotopic  digoxigenin-labelled riboprobes [200]. However,  this involved an 
industrialised and automated ISH and data-analysis platform  and ample resources, 
perhaps best suited for generating basic physiological data.
2.5.3 RT REACTION AND REVERSE TRANSCRIPTASES
The reproducibility  of qPCR has generally  proven  to be very  good and the RT reaction  step 
is believed to contribute most  of the variation  to the determination  of mRNA quantities 
[349],  making  the quality  of the cDNA  and the reproducibility  of the cDNA  synthesis 
major,  if not  the most  important,  determinants of reliable gene expression analysis [46, 
90, 186,  265,  401].  Especially  when  no stable reference genes or  synthetic spiking  RNA 
(see before) are utilised, both  absolute and relative (comparative) quantification  rely  on 
the premise that  the efficiency  of RT and qPCR reactions are similar across all  samples to 
be compared. Normalisation  of the genes of interest to some internal  reference gene,  or 
preferably  to a  set of reference genes [363, 395],  improves reliability, but  still requires that 
the relative efficiencies of the RT reactions for  the genes of interest  and the reference 
genes are consistent  from  reaction to reaction; quantification  without  external  qPCR 
standards extends this requisite  to the qPCR [46]. If a  single gene is selected for 
normalisation, it  should always be pre-validated for  the treatment or  condition  to be 
examined [68, 175, 324].
The importance of the quality  (and homogeneity  of quality)  of the RNA  to unbiased RT-
qPCR analysis has been  demonstrated in  several studies (see above), and an analytical 
framework to assess the quality  of RNA using several  parameters has recently  been 
conceived [401]. The effects of different  types (gene-specific,  random  oligomer  or  oligo-
dT) of primers used for  cDNA  synthesis have also been  assessed in  several studies [47, 
201,  349, 434],  but the performance of various RT  enzymes has received little  attention 
[47, 350].
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Retroviral reverse transcriptases are RNA-dependent  DNA polymerases that  are 
capable of using  RNA  as their template. These enzymes were first  discovered by  Temin 
and Mitzutani [358] and by  Baltimore [14]  in  1970 and have become widely  used in 
molecular  biology  [102]. The retroviral  RT enzymes are capable of using both  RNA and 
DNA  as a  template and have a  peculiar  partial endonuclease activity  called RNAse H, 
enabling the same enzyme to cleave and degrade the RNA template from  the synthesised 
DNA/RNA hybrid while producing  complementary  DNA  [51, 167].  They  are also much 
more error-prone than DNA-directed DNA polymerases,  which  (among  other  factors) 
enhances the genetic variability of retroviruses [258, 311].
The main  types of reverse transcriptase originate from  avian  myeloblastosis virus 
(AMV), and Moloney  murine leukemia  virus (M-MLV), with  possible modifications to 
improve their  performance [102]. (To be precise, the AMV  RT enzyme should be called 
AMV/MVA  RT, since it  does not originate from  AMV  but  from  myeloblastosis-associated 
virus [MAV],  a  natural  helper virus present in AMV  stocks [264].) Besides these two 
agents,  other  retroviruses and even  bacteria  may  also be utilised as sources of RT  enzymes 
[269,  336], but are generally  much  less used in  practice.  The best-characterised AMV- and 
M-MLV-derived enzymes differ  somewhat  in  structure and function,  both  requiring 
divalent  cations for  activity  [269].  The functional unit of AMV is a  heterodimer consisting 
of two subunits (smaller  α and larger β),  the smaller  one containing reverse transcriptase 
and RNAse H activity.  In  contrast, the M-MLV  enzyme contains just one polypeptide 
comprising  both  domains [102]. Compared with  M-MLV, native AMV  has been shown  to 
be more efficient [37],  and to function  at  higher  temperatures [102, 181],  but to possess 
significantly  greater  RNAse H activity  [66].  The main modifications to improve RT 
enzymes are aimed at  increasing  their  processivity  (amount and length  of cDNA  produced) 
and the fidelity  of transcription  of low  abundance mRNA  species. To achieve these aims, 
better enzymes are painstakingly being sought and the old ones modified.
2.5.4 PRECISION OF THE QUANTITATIVE REAL-TIME PCR
The absolute accuracy  of gene expression  measurements using  RT-qPCR is questionable, 
since the true RT  efficiency  cannot  be  known, and the methods employing  synthetic 
control  RNA are cumbersome for  routine analysis and riddled with  some technical 
difficulties (see before).  However,  in  assays measuring  genomic DNA  (e.g. copy  number 
profiling), excellent  accuracy  and reproducibility  can  be achieved by  careful  optimisation 
and meticulous data  analysis [67,  155]. The error  induced by  qPCR manifests itself on  the 
one hand in  systematic  differences in  reaction  efficiencies among different templates or 
different amplicons (genes), and on  the other  in  random  tube-to-tube (well-to-well) 
variations. The former  systematic  (template-to-template and/or  amplicon-to-amplicon) 
deviations in  reaction  efficiencies can  be minimised by  primer  and reaction  optimisation, 
experimental planning and repeated measurements.  In  quantification  relying  on  a 
standard or  calibration curve, the reaction efficiencies are assumed, or  adjusted,  to be 
equal in the standards and samples; this method may  be called absolute or  relative 
depending  on  whether  the  standard curve is based upon  known  units or  some relative 
quantities [67, 196, 306, 354]. 
Relative quantification  without external standard curves was originally  based on  an 
assumption of identical amplification  efficiencies of both  the gene of interest and the 
31
reference (calibrator)  gene [216], but has been  refined to compensate for  systematic 
efficiency  dissimilarities between the gene of interest  and the reference or  calibrator  gene 
or  genes [127,  267].  In  addition,  relative quantification without external standards but 
with  efficiency  correction  can  be performed without  the use of any  internal reference or 
calibrator  genes by  calculating  theoretical  fluorescence and thence copy  numbers at  the 
first  PCR cycle  [261].  This method allows a  formal separation  between quantification  and 
normalisation, and results in  practically  identical normalised results after  either  absolute 
or  relative quantification.  Considerable effort  has indeed been  invested in searching for 
and perfecting various quantification  strategies, with  or  without  external standard or 
calibration curves [127, 196, 354, 415].
Random  variation  in  the tube- or  well-specific  efficiencies can  be determined by 
modelling and fitting the real-time fluorescence curve [215, 300],  but this approach  has 
been  questioned due to its mathematical  complexity  and introduction of systematic errors, 
increased noise and/or  variance [261, 314, 432].  Currently,  there seems to be a  consensus 
on  omitting  the sample-specific PCR efficiencies and using  a  fixed or  mean  efficiency  per 
amplicon  for  quantification  [314]. Perhaps, therefore, individual tube-specific  efficiencies 
are not  employed in most of the automated software tools for  mRNA  expression 
quantification, normalisation and data analysis [127, 243, 267].
In  conclusion, the basic technical  determinants of the fidelity  of expression  analysis are 
largely  the choice of equipment,  primers and enzymes: Specialised (often  high-
throughput) instruments are used,  and the RT and PCR enzymes employed are nearly 
always commercial, their  manufacturer  thus supplying a  specific buffer  concentrate for  the 
reaction setup and providing  protocols for  the temperatures and reaction  times to be used 
in  both  reaction steps.  However, despite its apparent  ease and rapidity, the current  RT-
qPCR technique is not  without many  intricacies, and its careless use has led to some high-
profile failures [13].  In  response to the lack of consensus on  how  best  to perform  and 
interpret qPCR experiments,  a  set of MIQE guidelines has recently  been devised to 
promote better  experimental practice, leading  to more reliable and less equivocal 
interpretation of qPCR results [44].
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3 AIMS OF THE STUDY
The objectives of the present  thesis research  were twofold. In  the first  two studies (I, II), 
the goal  was to employ  the sensitivity  difference of the  L–E and H/W rats to assess the 
relationship between  TCDD-induced wasting syndrome and the changes or  basal mRNA 
levels of factors relating  to the AHR signalling  cascade, or  participating in feed intake and 
body  weight regulation. In  the second set  of studies (III,  IV), potential  RT-qPCR reference 
genes for  dioxin  studies were sought  and the robustness of various RT  and qPCR enzymes 
was examined. The specific aims of the studies were as follows:
1. To assess the constitutive mRNA levels and effects of TCDD treatment  on  mRNA 
expression  of Ahr and some other  bHLH/PAS proteins,  as well  as two cytochromes 
in the H/W and L–E  hypothalami (I);
2. To determine the influence of TCDD on  hypothalamic mRNA  levels of a  number of 
selected factors involved in feed intake and body weight regulation (II);
3. To compare the effects of TCDD on the aforementioned feed-intake factors with 
those of leptin and feed restriction (II);
4. To examine the stability  of the  expression  levels of a  number  of commonly  applied 
reference genes in  various tissues, including the hypothalamus, after  an  acutely  toxic 
dose of TCDD or reduced feed intake (III);
5. To compare various RT and qPCR enzymes and the behaviour  of four common 
reference genes in RT and qPCR reactions in a practical RT-qPCR setting (IV); and
6. To gain  a better  understanding of the factors contributing  uncertainty  to the RT-
qPCR technique (IV).
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4 MATERIALS AND METHODS
4.1 ANIMALS AND HOUSING
The studies were mainly  carried out in inbred TCDD-susceptible Long–Evans (Turku/AB; 
L–E) and random-bred TCDD-resistant  Han/Wistar  (Kuopio; H/W) rat strains (for 
resistance characterisation  see [281, 388]).  Some intermediately  resistant line B animals 
(derived from  crosses between  L–E and H/W  rats [378]) were used in  study  III. The rats 
were obtained from  the breeding colonies in  the SPF barrier unit  of the National  Public 
Health  Institute,  Kuopio,  and were 10–15  (L–E and H/W; males) or  15–20 (line B; 
females) weeks old at the time of the experiments.
The animals were housed singly  (line B rats in  groups of two to four) in  suspended 
stainless steel wire-mesh  cages in  artificially  illuminated animal  rooms with  a constant 
temperature of 21.5  ± 1.5  °C,  humidity  55  ± 10% and a  12/12  h  light/dark rhythm  (lights 
on  at  7.00 am). They  had free  access to tap water  and to pelleted (Lactamin  R36, 
Stockholm, Sweden) or  powdered feed (Ewos R36, Ewos,  Södertälje,  Sweden),  except  for 
some feed-restricted L–E groups (studies II and III),  for  which  the amount  of feed given 
was gradually restricted after corn oil administration.
The Animal Experiment Committee of the University  of Kuopio and the Kuopio 
Provincial Government approved the procedures and study  plans. The studies had the 
license numbers 03-53  (18  August  2003) and ISHL-2004-04429/Ym-23  (13  December 
2005).
4.2 CHEMICALS
TCDD was >99% pure as determined by  gas chromatography-mass spectrometry. It  was 
first  dissolved in  diethyl  ether  for  storage. For  dosing,  an adjusted volume of this solution 
was re-suspended in  corn  oil (Sigma  Chemicals, USA),  allowing  the ethyl ether to 
evaporate.  The dosing  solution  was mixed in a magnetic stirrer  and sonicated for  20  min 
before administration. The TCDD concentration  was adjusted to lead to an  identical 
dosing volume of 4 ml/kg in all experiments.
Lyophilised mouse recombinant leptin, CAS 181030-10-4  (Lot B36665,  Calbiocem, San 
Diego, USA),  was first  dissolved in 15  mM HCl and then  7.5  mM NaOH was added 
according  to the manufacturer’s instructions.  The final  concentration of leptin  was 
adjusted to 1 mg/ml using 0.9% NaCl.
4.3 EXPERIMENTAL DESIGN
The first  two studies (I and II) of the thesis were designed to measure the effect  of TCDD 
on  the hypothalamic gene expression  of some AHR-related bHLH/PAS proteins and 
hypothalamic factors known  to take part  in  the regulation of feeding  and metabolism. For 
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the rationale of the measured gene products see I and II, and sections 2.2.2, 2.2.3  and 
2.4.8 of the literature review.  The third study  (III)  was designed to examine the effect of 
TCDD on the expression of a  large number  of potential RT-qPCR control  genes in  various 
tissues,  and the final one (IV) to analyse the RT and qPCR stability  of four control genes 
and to compare RT and qPCR enzymes using a pooled RNA sample from rat hypothalami.
Table 1. Study and experimental outlines
a
 After RNA isolation, mRNA was further enriched from the total RNA (see 4.4).
b
 The expression measurements were carried out using microarrays.
c
 The results of experiment 4 with female line B rats are not discussed further in the  thesis.
In  studies I–III the animals were given a  single dose of TCDD (50,  100 or  [300 μg/kg  – 
line B]) by  intragastric  gavage (ig) or  an  equal  volume (4  ml/kg) of the corn  oil vehicle and 
killed for  sampling  at various time points, from  6  hours to 10 days,  after  the treatment. 
Leptin  (1.3  mg/kg; shown to reduce feed intake within  4  h  in rats [237]) was 
intraperitoneally  administered to some of the animals 2  hours before sampling in  study  II, 
and the feed intake of some control animals was gradually  restricted for  4  or  10  days (until 
sampling)  in  studies II and III to mimic  TCDD-induced wasting. Notably,  the TCDD doses 
employed are well above the LD50 value (18  μg/kg  [378])  of the  sensitive L–E strain, 
leading  to a  pronounced reduction in feed intake and body  weight,  while they  induce only 
minor effects on  H/W rats.  The timing of the sampling  in  studies I and II was considered 
to enable the detection  of both  early  (acute)  expression  changes at  6  hours,  “intermediate” 
changes at 24  hours and more advanced changes at  4  or  5  days.  The expected secondary 
gene expression  changes induced by  feeding reduction  and the resultant  negative energy 
balance were addressed by employing feed-restricted control groups in studies II and III.
There were no specific animal treatments in  study  IV, in  which the hypothalamic RNA 
of four  H/W rats was pooled for  later  RT  and qPCR reproducibility  experiments. The RT 
experiment  (A) started with  the pooled RNA, which  was reverse transcribed with  eight 
enzymes (enzyme 7  was used twice with  different  RT primers; see below).  Five parallel  RT 
reactions were carried out  with  each  enzyme, and the cDNA  levels of four  control genes of 
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Study Experiment Tissue Treatment Strains Sampling 
I Hypothalamus TCDD 50 μg/kg L–E and H/W 6 h, 4 d
TCDD 100 μg/kg L–E and H/W 5 da
II Hypothalamus TCDD 50 μg/kg L–E and H/W 6 h, 24 h, 4 d
TCDD + leptin L–E 4 d
Feed restriction
Feed restr + leptin
III 1 Liverb TCDD 100 μg/kg L–E and H/W 4 d
Feed restriction L–E
2 Liver, spleen TCDD 100 μg/kg L–E 10 d
Feed restriction
3 Hypothalamus TCDD 50 μg/kg L–E 10 d
4c Liver TCDD 300 μg/kg Line B 2 d, 7 d, 14 d, 32 d
IV A “RT” Hypothalamus None H/W
B “qPCR”
each  RT  reaction  were quantified with  real-time PCR in  two replicate PCR runs. Diluted 
cDNA  from  the previous RT experiment  was used in  the qPCR experiment  (B), and the 
same four  genes were again  measured from  each  of the five RT reactions. The 
measurements were performed with  six  real-time PCR enzymes and there were three 
repeats of each RT in  each  replicated PCR run. See the original publications (I–IV) for 
more detailed descriptions of the study designs.
4.4 SAMPLING, RNA ISOLATION AND REVERSE 
TRANSCRIPTION
The rats were killed by  decapitation  and the brain,  liver  and spleen were rapidly  removed. 
Hypothalami were dissected using  a  metal  brain  mould (RBM-4000, ASI Instruments, 
Warren, MI), making the rostral  incision  immediately  in  front  of the of the optic chiasm, 
the caudal  incision to the caudal border  of the mamillary  body, the dorsal incision  to the 
ventral border of the anterior commissure and lateral incisions to the medial borders of 
the tuber  cinereum  and mamillary  body  complexes [260].  Pieces weighing  approximately 
200  mg were sliced from  the left lateral lobe of the liver  and samples of a  similar  size were 
taken  from  the spleen (III).  The tissue samples were flash-frozen  in liquid nitrogen, and 
stored at −80 °C for subsequent analyses.
Total RNA from  the hypothalamic  samples (I–IV) was isolated using  TRIzol Reagent 
(Life  Technologies,  Eggenstein, Germany; I, II),  RNeasy  kits (Qiagen  Nordic, Crawley, UK; 
III) or  RNeasy  Lipid Tissue Mini kits (Qiagen; IV). The isolated RNA  was treated with 
DNAse I (Ambion, Cambridgeshire, UK) in  study  II, and in  studies III and IV,  employing 
the RNeasy  kits, DNase treatment  (Qiagen)  was performed on  the elution columns.  Total 
RNA  for  RT-qPCR from  the liver  and spleen samples (III) was isolated with  a  GenElute 
Mammalian  Total RNA Miniprep Kit (Sigma-Aldrich,  St. Louis, MO; liver  in  experiment 4 
and spleen)  or  with the TRIzol Reagent (Invitrogen, Paisley, UK; liver  in  Experiments 1 
and 2) and DNAse treated with  the DNA-free kit (Ambion).  For  microarray  analysis 
(Experiment  1), total RNA  was extracted from  liver  using RNeasy  kits (Qiagen, 
Mississauga,  Canada) and,  as before,  DNase treatment was carried out on  the elution 
columns. In  study  I, poly(A)+ RNA  (“mRNA”) was further  enriched from  total RNA  of the 
day-5  samples (for  SIM1  analysis) with  the MicroPoly(A)Purist  kit (Ambion,  Austin, TX). 
The RNA yield was always quantified and purity  checked by  UV  spectrophotometry, and 
RNA  integrity  was verified in  some samples using  an Agilent 2100  Bioanalyzer  (Agilent 
Technologies, Santa Clara, CA, USA).
Reverse transcription  (RT) reactions to produce cDNA for  qPCR in  studies I–III were 
conducted using  Omniscript reverse transcriptase (Qiagen,  Hilden,  Germany) with 
random  hexanucleotides (Roche, Mannheim,  Germany) or  (for hypothalamic samples in 
study  III) a  10:1  mixture of hexanucleotides (Roche) and oligo-dT (Sigma) as primers. 
cDNA  was synthesised from  1.2  μg  or  0.6  μg  of RNA  in  a  20-μl or  10-μl  reaction  volume, 
respectively,  and the reaction  mixture was incubated at  37  °C for  60  minutes for 
hypothalamic samples or  for  90  minutes for  liver  and spleen  samples. In study  IV, several 
RT  enzymes were used, but  the same amount  of RNA, 1.2  μg, was added to each  20-μl 
reaction and an identical  concentration  of unspecific primers (excluding  some of DyNAmo 
RT  repeats), a  10:1  mixture of hexanucleotides (Roche) and oligo-dT (Sigma).  In  addition, 
an  equal incubation  time of 60 minutes was employed (see IV  for  details regarding 
individual RT enzymes).
36
4.5 REAL-TIME PCR (I–IV) AND MICROARRAY (III) METHODS
The real-time PCR quantification  was based on  external  standard curves generated from 
linearised plasmid DNAs (I,  II)  or  isolated and purified PCR products (I, III,  IV). Plasmids 
were produced by  amplifying the cDNA  of selected animals and tissues (see above) by 
conventional  PCR with  the qPCR primers, and cloning  the PCR products into pCR-Script 
SK(+) Amp plasmids (Stratagene,  La  Jolla,  CA). The PCR product  standards were directly 
amplified from  cDNA  by  conventional PCR and purified from  preparative agarose gels. 
Concentrations of the plasmids and amplicons were measured by  spectrophotometry,  and 
standard curves were produced from  them  with  a  ten-fold dilution  series in  duplicate or 
triplicate  ranging from  10−1 down  to 10−14, depending  on  the transcript.  See publication  I 
and [184]  for  more detailed descriptions of the preparation  of the cloned standards, and 
publication  III for  the preparation  of the PCR product  standards and construction  of the 
standard curves.
Quantitative RT-PCR analyses were performed with  three real-time PCR instruments, 
employing  various qPCR enzyme premixes. The Rotor-Gene 2000 Real-Time 
Amplification  System  (Corbett  Research, Mortlake, NSW, Australia) and QuantiTect  SYBR 
Green  PCR kit  (Qiagen) were used in  studies I and III, the LightCycler  instrument (Roche) 
with  the Fast-Start  DNA  Master  SYBR Green I kit  (Roche) or  Dynamo SYBR Green  I 
Mastermix  (Finnzymes, Espoo, Finland) in  studies I–IV,  and the Rotor-Gene 3000A  Real-
Time PCR instrument (Corbett) with  six  qPCR enzyme premixes in  study  IV. The PCR 
reaction volume in  all instruments and enzyme premixes was 20 μl,  and it contained 
cDNA  originatin°g from  15  ng (I–III; Rotor-Gene), 20  ng  (I–IV; LightCycler) or 
approximately  7  ng (IV; Rotor-Gene) of total RNA (or  mRNA in  I; see RNA  isolation). See 
Table 2 for details of the genes measured from the hypothalamus in studies I–IV.
The PCR reactions in  the Rotor-Gene 2000  instrument were initiated with a  15-min 
incubation  step at  95  °C,  followed by  45  cycles of denaturation  at  94  °C for  20 s,  annealing 
at  61–64  °C (first cycle) to 55–58  °C for  20 s (usually  with  a  “touchdown” during  the first 
six  cycles)  and elongation  at 72  °C for  20 s.  In the LightCycler, there was an  initial 
incubation  at  95  °C for 10  min,  followed by  45  cycles each  consisting  of denaturation  at  95 
°C  for 15  or  10  s, annealing  at 59  °C  for 5  or  20 s and elongation  at 72  °C for  12  s or  10  s. 
The cycling  programs in  the Rotor-Gene 3000A  instrument  with  the six  qPCR enzymes 
compared (IV) were adjusted according to the manufacturer’s instructions. In general,  the 
cycling programs of 45  cycles were composed of denaturation  at  94–95  °C, annealing with 
touchdown  from  63  °C to 57  °C for  20–30 s and elongation at  72  °C  for  20–30 s. A  melting 
curve was generated in  all instruments after  amplification  to verify  the specificity  of the 
PCR reaction.  The cycling  protocols are described in  detail in  the original publications. 
Finally,  the standard curve–based absolute abundances of the genes of interest  were 
divided by  beta-actin  values of the same samples to normalise the amount  of cDNA  in  PCR 
reactions (I and II) or  expressed as cDNA  concentrations in  the qPCR sample (III, g/l; IV, 
ng/l), thus indirectly normalising them in the latter studies to the amount of total RNA.
The microarray  analysis in  study  III was performed with  Affymetrix  RAE230-2  arrays 
at  the Centre for  Applied Genomics of the Hospital  for  Sick Children  (Toronto,  Canada) 
following  standard manufacturer’s protocols. After  hybridisation, the array  data  were 
loaded into the R statistical  environment [299], preprocessed (normalised) using  specific 
packages of the Bio-Conductor  project  [101],  and annotated using  an  “in-house”  algorithm 
partly  developed by  Paul  C. Boutros at the Department  of Pharmacology, University  of 
Toronto, Canada. The data preprocessing and annotation are detailed in (III).
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Table 2. Gene information and sizes of transcripts measured from the hypothalamus in 
studies I–IV
a
 Gene names, symbols and RGD IDs: Rat Genome Database Web Site, Medical College of 
 Wisconsin, Milwaukee, Wisconsin. WWW (URL: http://rgd.mcw.edu/). Retrieved October 2012.
b  NCBI Reference Sequences (RefSeq): National Center for Biotechnology Information Web  Site 
 (URL: http://www.ncbi.nlm.nih.gov/). Retrieved October 2012.
c The RGD ID and RefSeq are for the mouse. The mouse sequence was used to design the 
 primers for Sim1, because at the time of contriving the primers, the rat sequence 
 (NM_001107641) was unknown. The primers subsequently proved to bear homology rates of 
 19/20 (F) and 23/23 (R) nucleotides to the rat sequence, and efficiently amplified a single 
 product of the expected size.
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Gene Symbol References, Size (bp) Study
Aryl hydrocarbon receptora Ahr 621557a, NM_013149b 199 I
Aryl hydrocarbon receptor nuclear 
translocator
Arnt 2153, NM_12780 162 I
Aryl hydrocarbon receptor nuclear 
translocator 2
Arnt2 2154, NM_12781 299 I
Aryl-hydrocarbon receptor repressor Ahrr 1559857, NM_001024285 161 I
Single-minded homolog 1 (Drosophila) Sim1 1320568, NM_011376c 158 I
Period homolog 2 (Drosophila) Per2 61945, NM_031678 183 I
Cytochrome P450, family 1, subfamily a, 
polypeptide 1
Cyp1a1 2458, NM_012540 361 I
Cytochrome P450, family 1, subfamily a, 
polypeptide 2
Cyp1a2 2459, NM_012541 473 I
Growth hormone secretagogue receptor 
(ghrelin receptor)
Ghsr 621397, NM_032075 199 II
Neuropeptide Y Npy 3197, NM_012614 188 II
Neuropeptide Y receptor Y5 Npy5r 3199, NM_012869 318 II
Agouti related protein homolog (mouse) Agrp 2068, NM_033650 191 II
Cholinergic receptor, muscarinic 3 Chrm3 2343, NM_012527 449 II
Pro-melanin-concentrating hormone Pmch 3358, NM_012625 494 II
Syndecan 3 Sdc3 621486, NM_053893 382 II
Hypocretin (orexin) Hcrt 2786, NM_013179 200 II
Hypocretin (orexin) receptor 2 Hcrtr2 2788, NM_013074 180 II
Leptin receptord Lepr 3001, NM_12596 495 II
Insulin receptor Insr 2917, NM_017071 497 II
Proopiomelanocortin Pomc 3366, NM_139326 247 II
Melanocortin 4 receptor Mc4r 3057, NM_013099 510 II
CART prepropeptide Cartpt 2272, NM_017110 343 II
Neurotensin Nts 621612, NM_001102381 241 II
Urocortin Ucn 3929, NM_019150 245 II
Histidine decarboxylase Hdc 2790, NM_017016 405 II
Histamine receptor H1 Hrh1 2830, NM_017018 396 II
Actin, beta (beta-actin) Actb 628837, NM_031144 298 I–IV
Glyceraldehyde-3-phosphate 
dehydrogenase
Gapdh 2661, NM_017008 170 III, IV
Phosphoglycerate kinase 1 Pgk1 619878, NM_053291 180 III, IV
Succinate dehydrogenase complex, 
subunit A
Sdha 621557, NM_130428 160 III, IV
4.6 STATISTICAL ANALYSES (I–III)
In  study  I,  differences between  control and TCDD-exposed groups and between 
corresponding  groups of the strains at  each  time point  were assessed using  two-tailed t-
tests for  independent samples.  The basal mRNA levels of CYP1A  were below  the detection 
limit in  most  of the control samples,  and these were assigned the value of the lowest 
measurable sample before analysis. In  study  II,  analysis of variance (ANOVA) for  repeated 
measures followed by  t-tests were used to evaluate the effect of TCDD on  daily  feed 
consumption and body  weight  change.  Two-way  ANOVA  were used to determine the 
statistical significance of TCDD and leptin  treatment  effects on the hypothalamic mRNA 
levels at each  time point  and for  each  strain, followed by  t-tests between  control  and either 
TCDD- or  leptin-treated groups.  At  96  h  in L–E rats, a  similar  approach was used to 
evaluate the effects of restricted feeding  and leptin.  In  both studies,  effects or  differences 
were considered to be statistically significant if the p-value was <0.05.
In  study  III, the quantitative RT-PCR data  were first  checked for variance homogeneity 
across groups to be compared using Levene’s test.  Data  with  homogeneous variances and 
more than two groups were analysed within  each  strain/line by  one-way  ANOVA followed 
post-hoc (p < 0.05) by  Duncan’s multiple range test to detect  the deviating  group(s). If 
non-homogenous variances were found, a log10-transformation  was performed on  the 
data  and Levene’s test run  afresh, and if this procedure did not  homogenise the variances, 
non-parametric Kruskal–Wallis ANOVA  tests followed by  Mann–Whitney  U-tests for 
group-wise comparisons were employed.  In experiment 4,  the controls were pooled from 
two time points after  vehicle treatment, since there were no significant  differences 
between  the time points for  any  variable.  The microarray  data were analysed by  fitting the 
following  linear  model for  the normalised expression  value of each  individual ProbeSet  of 
the arrays:
Expression = (H/W) + (L–E) + (TCDD) + (feed) + (feed:L–E) + e,
where (H/W) and (L–E) are the separate effects of each  strain,  (TCDD) and (feed) are 
indicators (effects)  of TCDD and feed-restriction  treatments,  (feed:L–E) is an  interaction 
term and e the error term.
After  empirical  Bayes moderation  of the standard error  [339], model-based t-tests 
based on a  predetermined contrast matrix  were employed to extract  the M (differential 
expression) and p values for  each  contrast  and gene after a  false discovery  rate adjustment 
for  multiple testing [80].  The statistical  analysis of the microarray  experiment  is detailed 
in (III).
4.7 MODELLING OF RT AND qPCR ROBUSTNESS (IV)
In  the statistical modelling  of study  IV, the RT and qPCR reactions were treated as a  series 
of multiplicative components with  unknown  efficiencies and variances. The multiplicative 
efficiencies were converted into additive effects by  logarithmic transformation of the 
measured expression  values leading to a  log-normal  distribution  of the various efficiency 
parameters [209].  This also resulted in  a  reasonable scaling  of the expression levels of the 
measured genes and RT and enzyme efficiencies.  Separate linear multilevel  (hierarchical) 
models were fitted to RT and qPCR experiment  data  with  OpenBUGS software (version 
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3.2.1,  rev  781) [217] using  Bayesian  methodology, and both  infinite-population  (σ) and 
finite-population  sample (sd) standard deviation  parameters were used to extract  all 
relevant  information  from  the models. Where applicable,  the infinite and finite-population 
log-normal standard deviations were converted to coefficients of variation (CV) on  a 
natural scale [209] to be more comprehensible.  The uncertainties of the parameters were 
expressed as Bayesian  credible intervals.  The model construction  is explained in  detail and 
the mathematical formulas for  calculation of the CVs and finite population  sd parameters 
are given in (IV).
4.7.1 RT REACTION MODEL
In  the RT model,  the RT enzymes constituted the highest  hierarchical  level,  inside which 
nested the five replicate RT reactions (tubes)  for  each  enzyme with  enzyme-specific 
variance components. The enzyme parameters (E) were set as fixed effects without 
distribution parameters,  treating  the RT  reaction  replicates as five trial runs of nine 
“enzyme machines” producing cDNA  with  pre-set,  unknown  identical  settings (the true 
abundances of the RNA  transcripts) and with  enzyme-specific fixed unknown  efficiencies. 
The four  studied RNA  transcripts,  reverse transcribed among  a myriad of other RNAs in 
each  tube, comprised the lowest level  of the model with  gene-specific variances. The 
duplicate qPCR reactions were omitted from  the model,  allowing  the qPCR effect  to sink 
into the error variance term.
For each (log-transformed) measurement Yi:
Yi ~ Normal(μi,σ2) ,
where σ2 is the measurement  error variance component  with  prior  σ ~ U(0,20),  and the 
mean is
μi = ETGe(i)t(i)g(i) ,
where prior  ETGetg ~ Normal(Ee, σ2eg).  The nine enzyme effects are fixed with  priors Ee ~ 
U(-100,100), e = 1,…,9  and variances σ2eg = σ2e + σ2g ,  e=1,…,9  and g = 1,…,4, with  priors σe 
~ U(0,20)  and σg ~ U(0,20). Hence,  the variance components of reaction  tubes (between 
tube variability) within  enzymes are assumed to be  common within  each  enzyme, and the 
variance components of genes (between-gene variability) within reaction  tubes within 
enzymes are assumed to be common for each gene.
4.7.2 qPCR MODEL
In  the qPCR model,  the highest level  was the RT reactions (tubes, T), inside which  nested 
the four  studied genes (TG),  and inside these  the six  studied qPCR enzymes (TGE).  The 
fourth  level (GER) was constructed by  nesting  the two qPCR runs inside genes and 
enzymes,  omitting  the tube effects, since each qPCR run  is unique only  for  each  enzyme 
and gene combination. The highest  level  of the PCR model,  comprising  the five RT 
reaction repeats,  was modelled as random  effects using  hierarchical centring. Here,  the μ 
value of parameter T corresponds to the mean  cDNA  concentration of the four  transcripts 
produced by RT enzyme 5.
For each (log-transformed) measurement Yi:
Yi ~ Normal(μi,σ2) ,
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where σ2 is the measurement  error variance component  with  prior  σ ~ U(0,20),  and the 
mean is 
μi = Tt(i) + TGt(i)g(i) + TGEt(i)g(i)e(i) + GERg(i)e(i)r(i) ,
where the five RT  reaction tube effects are modelled using  the hierarchical centring 
technique as random  Tt ~  Normal(μtube,  σ2tube),  t  = 1,…,5  with  general  mean  μtube and 
variance component σ2tube setting  priors μtube ~ Normal(0, 104)  and σtube ~ U(0,20).  Within 
each  reaction  tube,  the effects of the four  measured genes are modelled as random  TGtg  ~ 
Normal(0, σ2g), g=1,…,4,  with  gene-specific variance components with  prior  σg ~  U(0,80). 
Within each  gene,  and within  each reaction  tube, there are six  enzymes whose effects are 
modelled as random  TGEtge ~ Normal(0, σ2e),  e=1,…,6, with  enzyme-specific  variance 
components with  prior  σe ~ U(0,20).  The random  effects T, TG and TGE are hierarchically 
nested, but  assume a  common  variance component  of T for  all reaction  tubes, common 
variance components of TG within genes and common  variance components of TGE 
within  enzymes.  Additionally, random  effects were also assumed for  the runs within 
enzymes within genes GERger  ~  N(0,  σ2run),  with  a  single variance component  σ2run with 
prior σrun ~ U(0,20).
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5 RESULTS
5.1 THE EFFECTS OF TCDD ON SELECTED bHLH/PAS 
PROTEINS AND CYPS
In  study  I, the mRNA  expression of five bHLH/PAS proteins,  Ahr,  Ahrr, Arnt, Arnt2 and 
Per2,  as well as Cyp1a1 and Cyp1a2 (Table 2) was measured from  the hypothalami of 
untreated and TCDD-treated (50  μg/kg)  H/W and L–E rats after  6  h and 4  days. The 
detection  of Sim1 was an  exception: the analysis was performed using  cDNA samples 
derived from  hypothalamic  mRNAs of both  strains, treated with  100 μg/kg  of TCDD 5 
days before. The measured dioxin  signalling related proteins, Ahr,  Ahrr,  Arnt and Arnt2, 
attested to minor strain-specific  variation  in  constitutive expression  and reaction  to TCDD 
treatment. The amply  present Ahr mRNA was about  two- to three-fold more abundant in 
L–E than in  H/W rat  hypotalami, and TCDD did not affect  its levels.  In  contrast,  the 
constitutive levels of Ahrr mRNA  were very  low,  but  TCDD increased them  considerably  in 
both  strains, amounting  to an approximately  10-fold increase in  L–E rats and 5-fold in  H/
W rats.  The relative constitutive levels of Arnt mRNA  were about  a  1000-fold lower  than 
those of Arnt2 mRNA, but  except for  this difference in  basal apparent concentrations,  the 
overall  expression patterns of Arnt and Arnt2 were somewhat  similar; the L–E rats 
expressed about  two-fold higher  levels of Arnt mRNA  at each time point  than  H/W rats, 
while in  Arnt2 the difference between the strains was smaller.  However, there was no 
detectable effect of TCDD in either strains or time points.
Constitutive expression  of the other measured bHLH/PAS proteins Sim1 and Per2 was 
very  low; Sim1 was even  analysed from  cDNA  reverse transcribed from  enriched mRNA 
(see before).  TCDD treatment  did not significantly  affect  the expression of either  of them, 
while there was a  slight downward tendency  of SIM1  and upward tendency  of Per2 in  L–E 
rats.  Akin  to Sim1 and Per2,  the basal  mRNA  abundances of cytochromes were low 
(mRNA  levels of Cyp1a2 were below  the detection  limit  in most  of the control  samples), 
but contrary  to Sim1 and Per2 their  expression  was drastically  increased after  TCDD 
treatment. The TCDD-induced levels of Cyp1a2 mRNA  were significantly  higher  in  L–E 
than in H/W rats.
5.2 TCDD AND HYPOTHALAMIC FEEDING-REGULATORY 
FACTORS
In  study  II,  the mRNA expression  of 18 hypothalamic factors (Table  2),  known  to take part 
in  the regulation  of eating  and metabolism, was measured by  quantitative RT-PCR at  6  h, 
24  h  and 4  days after  a  single dose (50  μg/kg)  of TCDD or corn  oil. The effects of TCDD 
were compared with  those of leptin (1.3  mg/kg; given  2  h  before sampling)  and with  feed 
restriction.  TCDD alone mainly  modified the expression  of orexigenic factors and, as a 
general  rule,  it  initially  suppressed mRNA  levels, but later  there was a shift  to increased 
expression. This was seen  in both  strains,  although  TCDD-sensitive L–E rats responded at 
a  faster  rate. In  anorexigenic  factors, there was a  similar  general  pattern, except that the 
42
late increase was missing  in  L-E rats. Moreover, the number  of significant  changes was 
clearly fewer and their magnitude smaller than in the case of orexigenic factors.
At 6  h,  TCDD reduced Npy, Npyr5 and Pmch  in  L-E rats,  and hypocretin (orexin) 
receptor  2  (Hcrt) in  both  strains, while at  24  h decreases were mainly  recorded in  H/W 
rats.  In L–E rats,  the expression  of Npyr5 was still low, even  as the other  factors had 
returned to normal or  exhibited already  elevated (e.g.  Pmch)  levels.  At  96  h,  only  increases 
were recorded,  with  Agrp  being  strongly  up-regulated in  both  strains. Npy  was increased 
in L–E rats, roughly to a similar degree as described after a 48-h feed deprivation [352].
Leptin  influenced the expression  of both  orexigenic  and anorexigenic  factors in  a  more 
even  manner,  but the statistically  significant effects were conspicuously  clustered at  the 
first  time point,  especially  in  L–E rats. At  6  h  after  TCDD or  corn  oil  exposure,  leptin 
almost  solely  brought  about  suppressive changes; Pmch,  Pomc and Cartpt displayed 
similar  alterations in  expression  in  both strains at  this time point,  whereas several 
anorexigenic factors were down-regulated only  in  the L–E strain. A  decline in  Pomc 
expression  after  leptin  administration  was detected in  both  strains at  6  h  and in  L–E rats 
at  24  h.  At  later  time points,  the most prominent  leptin effects were decreases in  Agrp  and 
Pmch expression  seen  in  H/W  rats, and increased expression  of insulin  receptor  (Insr) 
detected in  L-E rats.  Four-day  progressive feed restriction,  mimicking  the action of TCDD, 
induced a  statistically  significant  reduction  in  Cartpt and histamine receptor H1, and an 
increase in  Ghsr (ghrelin  receptor) and Agrp mRNA  levels, while there was a  non-
significant increase in Npy.
5.3 REFERENCE GENES IN TCDD-TREATED RATS
In experiment 1  of study  III,  hepatic mRNA  levels of 18  commonly  employed 
normalisation  genes were measured by  microarray  on day  4  after  TCDD (100 μg/kg)  or 
corn oil administration. Of these, eight  (44%) appeared to be responsive to TCDD in  L–E 
and four (22%) in  H/W  rats. In  addition, five genes (28%) exhibited altered expression 
after  feed restriction. Three of these latter  genes were also affected by  TCDD, with  one 
being modulated in  opposite  directions by  TCDD and feed restriction.  In  experiment  2, a 
selected subset  (14)  of the housekeeping  genes analysed with  microarray  was verified by 
qPCR,  and expression  of the same battery  of genes was further  determined at  a  later  time 
point  (10  days)  in  the L–E strain.  The data  generated by  the two independent methods 
proved to be astonishingly  convergent with  regard to both  the occurrence and direction  of 
changes and the degree of induction  or  repression; only  in  two cases was there a  distinct 
difference in  outcomes.  Furthermore, the expression  patterns remained fairly  constant  at 
4  and 10  days post-exposure, and strikingly, whenever an  mRNA concentration  was 
affected by  either treatment  (TCDD or  feed restriction),  there were statistically  significant 
departures from  control  levels on  both  occasions.  In  most  cases,  the direction  of change 
also remained the same.
Control  genes Gapdh, Pgk1 and Sdha,  which  had exhibited the most  stable expression 
levels in  livers of L–E, H/W and line B rats,  were further explored in  the hypothalamus 
and spleen  of L–E rats (experiments 2  and 3).  Actb  was also included to the testing, as it 
was (at  the time) the most  commonly  used reference gene in  RT-qPCR, and was also 
employed in  studies I and II. In  the hypothalamus,  all  four  reference genes retained their 
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basal levels at  10  days after  TCDD (50 μg/kg) administration,  while in the spleen  a  TCDD 
dose of 100  μg/kg induced a  two-fold increase in  Sdha expression  without  any  apparent 
influence on the other  three genes examined. However, no such  effect  was discernible in 
feed-restricted control  rats.  Notably, TCDD has been shown  to be a  fairly  strong  inducer  of 
Gapdh  transcription  in vitro  [227], while we did not  record statistically  significant 
departures from  control  levels in  any  of the tissues examined.  The fact  that  feed restriction 
brought  about  a  repression  of up to 50% in  Gapdh mRNA expression in  the liver  and that 
no such  impact  occurred in  TCDD-exposed rats with  a  comparable body  weight loss also 
argues for  a  moderate induction  capability  also in  rats in  vivo. In  this case, the induction 
simply appears to be masked by an equally powerful opposite force.
5.4 RT ENZYME EFFICIENCY AND REPRODUCIBILITY
In  the first  part of study  IV  (A),  equal amounts of RNA  from  a  pooled hypothalamus-
derived RNA  sample were reverse transcribed in  parallel  reactions (in  five replicates)  with 
eight  RT enzymes,  one enzyme with  and without  oligo-dT  primers.  The four control  genes 
(Actb, Gapdh,  Sdha and  Pgk1; Table 2) found in  study  III to be stably  expressed in 
hypothalamus after  TCDD administration were then  measured with  qPCR from  the 
resulting  RT reaction products in  9×5  cDNA batches.  Based on raw  data,  the RT enzymes 
generally  exhibited reasonable coherence in  their  gene-specific  reaction  efficiencies. 
However,  enzyme 8  was much less productive than the others and formed 2–4  log10 units 
less cDNA. According  to the Bayesian  multilevel model for the RT reactions (model 1),  the 
source (AVM, M-MLV  or  unknown) or  RNAse H activity  of the enzymes 1–7  had only  a 
slight effect  on  the general  efficiency  of the RT reaction.  Nevertheless,  the only  (known) 
AMV-based enzyme yielded the highest parameter  efficiency  value,  and conversely  the RT-
reactions from which the oligo-dT primers were omitted exhibited the lowest efficiency.
The infinite-population  sd parameters measuring  general enzyme-specific 
reproducibility  of the reverse transcription fell into two loose groups: Enzymes 4  to 8 had 
their  parameter  medians,  expressed as coefficients of variation  (CVs) on a  natural  scale, 
between  13% and 20%,  and 1,  2  and 3  between  29% and 56%. The known AMV-based 
enzyme showed the worst  enzyme-specific RT reproducibility,  but RNase H activity  did 
not seem  to have a  definite effect.  Analogous finite-population sds,  measuring  variation 
among  RT reactions within  enzymes, also did not  reflect  an  effect of RNase H  activity, 
while pinpointing  enzymes 1,  2  and 8  as the least  precise.  Notably, the equivalent  infinite- 
and finite-population variance components of the qPCR model (model 2), employing RT 
enzyme 5, were smaller than those of the RT model.
The RT enzymes reverse-transcribed Gapdh and Pgk1 in line with  their  general  RT 
precision,  with median  CVs of enzymes 4  to 8 being  15%  to 20%  and 16% to 23%, 
respectively.  In  contrast, the RT efficiency  precision  of the Actb and Sdha  genes was more 
variable,  with  considerably  worse overall CV  median  values from  nearly  40% to more than 
100% (excluding  enzyme 8  and the Sdha  transcript).  The most  consistent  enzymes in  Actb 
transcription  were (in  order  of worsening  precision) 7, 8,  4, 5  and 1, enzymes 2,  3  and 6 
exhibiting larger  variation.  The most reproducible enzymes in  Sdha transcription turned 
out to be enzymes 5,  4  and 6, while enzymes 1  and 8  (CVs 103% and 183%) were 
substantially less precise.
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5.5 qPCR REPRODUCIBILITY AND RT REACTION ROBUSTNESS
In  the second experiment  (B) of study  IV, the five cDNA  batches produced by  one of the 
RT  enzymes (enzyme 5)  were used afresh  to compare six  qPCR enzymes. The four 
previously  used control genes were again  quantified with  the qPCR enzymes, and a  second 
Bayesian  multilevel model (model  2) was constructed for  the expression  values,  enabling 
the comparison  of the posterior  distributions of analogous parameters of the two models. 
The raw  data  from  the qPCR experiment  demonstrated considerable heterogeneity,  and 
accordingly, there was a  marked difference in  the average (general)  reproducibility  of the 
qPCR enzymes: The infinite-population  qPCR precision  parameter  medians (expressed as 
CVs) of qPCR enzymes 1, 2, 4  and 6  were 3%–5%, while those of enzymes 3  and 5  were 
11%. These infinite-population qPCR variance components of individual  enzymes thus 
varied from  values smaller  than Gapdh and Pgk1 finite-population  RT sd parameters to 
the same magnitude as Actb and Sdha RT sd parameters.  However, similarly  to the RT 
model, the gene-specific finite-population  qPCR sd parameters (measuring  gene-specific 
qPCR reproducibility  over all qPCR enzymes)  were almost  identical. The reproducibility  of 
the qPCR step thus varied very little among different transcripts in both models.
The finite-population  gene- and enzyme-specific sd parameters attached to Actb and 
Sdha RT  were 2  to 4  times larger  than  Gapdh and Pgk1 sds in  both  RT and qPCR models, 
whereas the difference was 2  to 3  orders of magnitude in  the corresponding  infinite-
population parameters. This led to infinite-population  gene-specific  RT variation CV 
medians of 9% for  Gapdh and 11% for  Pgk1 according  to the RT model, and approximately 
5% for  both  genes according to the qPCR model  – and enormous,  non-meaningful CVs for 
Actb and Sdha in  both  models.  Consequently,  the intrinsic RT efficiencies of the “stable” 
Gapdh  and Pgk1 transcripts seem  to closely  follow  the general transcription  efficiency  in 
each  RT reaction  and have little variation, while the “unstable”  Sdha and Actb transcripts 
appear  to have their  own independent  intrinsic  RT  efficiencies and exhibit somewhat less 
stability  from  one RT  reaction to another.  Finally,  there were salient differences between 
replicate runs in  the qPCR experiment  (enzymes 2  and 3  generally  exhibiting  the smallest 
differences).  However,  this variation  did not seem  to be gene or enzyme related,  but  might 
be related to the use of external standard curves.
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6 DISCUSSION
Extensive research  efforts have been focused on  elucidating the mechanisms of obesity 
and the physiological regulation  of energy  homeostasis,  while the dioxin-induced wasting 
syndrome has attracted surprisingly  little research  interest,  despite the fact  that TCDD is 
an  extremely  potent  compound in  lowering  body  weight  and reducing appetite.  Thus, the 
resolution  of the pathogenesis of the wasting  syndrome would be important  not only 
toxicologically  but also physiologically,  and as a  continuation  to this reasoning,  the 
hypothalamus, the  major  centre of food intake and body  weight regulation, seems an  area 
worth  scrutiny  as a  participant in  the derailment. Moreover, the simplest  approach  to 
tackle a  pathophysiological process,  starting  out from  AHR-mediated transcription 
alterations, would be to employ  the sensitivity  difference between  L–E – H/W  rats in 
mechanistic studies and use RT-qPCR as a  means to measure the gene expression  changes 
of the factors relating  to energy  balance. However,  the selection  of the CNS target and the 
technique of measurement  both  induce a  number of predicaments that render  the 
inferences less certain  and limited in scope.  Below, the findings of the thesis studies will 
be discussed in this context.
6.1 HYPOTHALAMIC bHLH/PAS GENE EXPRESSION 
ALTERATIONS AND WASTING
The constitutive hypothalamic expression  levels of Ahr,  Arnt and Arnt2 were moderately 
higher  in  the sensitive L–E than in  resistant H/W rats,  and concordantly  TCDD produced 
an  approximately  two-times larger  induction  of Ahrr in  L–E than in  H/W  strain.  These 
differences, however, are most  likely  not  causally  related to the development  of the 
wasting  syndrome.  The DRE binding of the AHR/ARNT  heterodimers is known  to occur 
similarly  in  both  rat  strains,  and their  sensitivity  difference is firmly  established to be 
caused by  the difference in  the transactivation  domain  (see 2.2.2).  In  addition,  the 
abundance of Ahr mRNA  has been shown not  to affect  TCDD sensitivity  in  female and 
male C57BL/6  mice livers [274],  and finally,  the astonishingly  uniform  increase in  the 
expression  levels between  the 6  h  and 96  h  time points,  regardless of strain  or  treatment, 
suggests time to have an  independent  effect  on  their  mRNA  abundance.  The time 
dependence of expression  could be explained by  technical reasons (elaborated further  in 
6.3) and/or  be related to circadian rhythmicity  and the anatomical  level of sampling. Ahr 
mRNA  has been  demonstrated to exhibit circadian variation  in  SCN,  with  peak expression 
occurring  at  light–dark  transition [241],  while Arnt or  Arnt2 rhythmicity  has not  been 
studied in  the brain. We did not  pay  particular  attention  to the similar  circadian 
adjustment of the sampling  in  study  I,  which  may  have induced the variation.  Targeting 
the whole hypothalamic block has the advantage of measuring  a  “total”  effect,  but it  has 
the definitive disadvantage of diluting  and adding  up individual, possibly  conflicting, 
alterations at the level of single nuclei.
In  previous studies,  Ahr and Arnt mRNA  have been shown  to be widely  expressed in 
the adult  rat brain, with  especially  high levels occurring  in the caudal ARC [144, 159,  266]. 
In  comparison, expression  of the Ahrr gene has not been  investigated in  rat the CNS,  and 
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the two reports in mice are partly  conflicting.  Huang  et al. [143] noted the basal 
abundance of Ahrr mRNA to be high  in  the pituitary, but  low  in  the cerebellum  and 
cortex, and negligible in the hypothalamus, while Bernshausen  et al.  [21] found especially 
high  levels of Ahrr mRNA  throughout the brain, and also reported the expression  to 
diminish  by  two orders of magnitude in  Ahr-deficient  mice.  At the protein  level,  strong 
AHRR immunoreactivity  was seen in  the mouse hippocampus and cortex,  and staining 
was recorded in the nuclei of several neurons throughout the hypothalamus [86].  The 
expression  of Arnt2 is primarily  confined to the brain  in  adult  mice [75, 134],  and in  the 
rat  hypothalamus the highest expression  of Arnt2 mRNA  has been  found in  the SON and 
the PVN, whereas low  or moderate levels have been  detected in  most other  hypothalamic 
regions [266]. The effect  of TCDD on AHR signalling  cascade molecules in  the brain has 
previously  been  addressed in  only  two studies: In  SD rats,  a  single low  dose of TCDD (10 
μg/kg)  did not  alter  Ahr expression  in  the hypothalamus, although  a slight  increase in 
Arnt emerged 28 days after  treatment  [144].  Concordantly,  in  129/SV-C57BL/6  cross mice 
hypothalami, a  low  sublethal (50  μg/kg) TCDD dose did not significantly  modify  either 
Ahr or  Arnt,  while Ahrr mRNA  was sharply  increased [143],  in  keeping  with  several other 
tissues [94].
The other  bHLH/PAS family  genes, Sim1 and Per2, did not  show  any  marked 
alterations in response to TCDD,  and there was an expected strong  rise in  the Cyp1a1 and 
Cyp1a2 expression  (see 2.2.3  and 2.3.2), the latter  exhibiting  a  larger  induction  in  L–E 
rats.  Similarly  the AHR-related proteins,  these findings speak against  a  decisive role of 
these factors in the development of wasting  syndrome, but  again  stress the importance of 
timing and targeting  of the sampling. SIM1  is involved in  hypothalamic PVN and SON 
development and food intake regulation  (see 2.2.1),  and ARNT2  appears to be required for 
its function  [140, 169, 229]. Accordingly, the expression  of Sim1 mRNA  has been  shown to 
be regulated by  AHR–ARNT2  and to react  to TCDD in vitro [428],  while no other  studies 
have addressed this in vivo.  The clock  genes Per1 and Per2 are strongly  expressed in  the 
rat  SCN [332], and some findings support  a  role for  them  in  the modulation  of AHR-
mediated responses to TCDD in  peripheral tissues [241, 295-297].  However, in  a  recent 
study  employing  in vitro TCDD treatment of explanted tissues, including  SCN, from 
PER2::LUCIFERASE mice,  no TCDD-induced alterations in  PER2  rhythms were found, 
suggesting  that the mammalian  circadian  system  is resistant to TCDD [263].  The 
induction of Ahrr and the cytochromes attest  to a  functional AHR signalling  cascade being 
present  in  the hypothalamus.  However,  there is compelling  evidence of the xenobiotic 
metabolism  mainly  being operational  in  vascular  and other non-neural tissue of the brain 
(see 2.2.3),  thus prompting  anatomically  more detailed sampling to establish  the role  of 
CYP induction in neurons in vivo.
6.2 NEUROPEPTIDE CHANGES
In  study  II, both  TCDD and leptin  influenced the expression of a  wide variety  of orexigenic 
and anorexigenic mediators, but two major  features distinguished their  effects,  especially 
in  the TCDD-sensitive L–E rats.  The great majority  of alterations elicited by  TCDD were in 
the orexigenic side,  while leptin  affected in  a  fairly  uniform  manner  both  orexigenic and 
anorexigenic peptides and their  receptors.  Also,  the effects of leptin  generally  took place at 
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the first  time point  of measurement, whereas they  were more evenly  distributed in  the 
case of TCDD. In fact,  in H/W rats the bulk  of significant  TCDD-induced alterations 
occurred at  the two last  time points, and  furthermore,  there was a conversion  in  the 
direction of change from  decreased to increased expression  at  the last time point  (4  days). 
Resembling  the effect of TCDD, the imposed mild feed restriction  also brought about  an 
increase in  two orexigenic  factors and a  reduction  in  two anorexigenic factors. Of the 
individual factors,  Pmch was increased at  48 h and Npy at  96  h  after  TCDD administration 
in  L–E rats.  The latter increase was of a  roughly  similar  degree to that  described after a 
48-h feed deprivation [352].
Collectively,  TCDD did not completely  abolish  mRNA  production  or  induce a marked 
and consistent  over-expression of any  of the studied neuropeptides or  receptors,  and there 
was a conspicuous lack  of an  effect  on  the hypothalamic reference genes in studies I,  II 
and III. A  severe cytotoxic  effect  on, or  permanent hyperexcitation  of the cells taking part 
in  eating  regulation  in the hypothalamus thus seems unlikely. Rather,  these findings 
suggest that  the late elevation of orexigenic mediators such as Npy and Agrp  may  be a 
compensatory  reaction  to ongoing  body  weight  loss,  and the increased Agrp  expression 
appears to be a  very  sensitive response to lowered metabolic fuel availability. The 
clustering  of leptin’s effects at  the first time point and unexpected reduction  of 
anorexigenic factors,  especially  in  L–E rats,  might be caused by  the marked surplus in 
day-time energy  from  the corn  oil  vehicle,  possibly  coupled with  handling stress.  The L–E 
rats exhibit  prominent  feeding  peaks at dark-light and light-dark  transition  phases,  but 
generally  consume a  smaller  proportion  of their  total  daily  ration  during the light  hours 
than H/W rats [202, 203].
Notably, two other  studies that  have directly  addressed the effect of TCDD on 
hypothalamic neuropeptides at the level  of single nuclei  using  in situ  hybridisation  have 
demonstrated some TCDD-specific alterations. A  sublethal TCDD dose (15  μg/kg) in SD 
rats brought  about an  increase in  Npy, Pomc  and Cart mRNA in  the ARC at  a  6  days,  and 
in  the LHA  Pmch expression  was also elevated [86].  In  line with  these findings, a  dose (50 
μg/kg)  close to the LD50 value of the same strain  of rat  increased Pomc  mRNA  abundance 
in  the ARC at  7  and 14  days; at  the latter time point, a  significant increase was also found 
at  lower  doses [236].  Differences in  methodology, rat  strain, TCDD dose, and the time of 
sample harvesting  impede direct  comparisons between  the experiments,  but  for  Npy and 
Pmch, similar changes were found in study II in L–E rats at 24 or 96 h.
The straightforward experimental  regime of measuring gene expression by  RT-qPCR in 
hypothalamic blocks at  fixed time points after  TCDD and/or  leptin administration is well 
suited to determining  general  impacts on  a  given  transmitter  or  receptor, but  has some 
technical  (see 6.3)  and methodological limitations.  In keeping  with  the bHLH/PAS 
proteins, changes confined to a  localised point  may  elude detection,  and the possibility  of 
reciprocal cancellation  or  dwindling of effects seems even  more probable considering  the 
complex neurophysiology  and anatomy  of the hypothalamus.  Moreover, dissociation  of 
the primary  dioxin  effects from  the secondary  outcomes of wasting  calls for  focusing on 
the early  stages of intoxication  and/or  meticulous employment  of pair-fed controls.  The 
issues relating to the anatomical sampling accuracy  and possible subtle interactions 
between  treatments and unforeseen  confounding  factors are exemplified by  the 
unexpected leptin effects. The complexity  of the  feeding  regulation  has also been  well 
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demonstrated in Npyr5 knock-out  studies,  in  which  obesity  has surprising  resulted 
despite inhibition of the NPY system [130].
The inter-strain  differences in  the physiology  of energy  balance regulation  may  even 
extend beyond the AHR-mediated sensitivity  to the wasting  syndrome, as evinced by  the 
above-described notable divergence in responses to leptin  and circadian  feeding  patterns, 
and the temporal differences in  expression responses. Furthermore,  the H/W and L–E 
strains vary  in  metabolic  parameters and feeding  responses.  Male H/W rats have higher 
serum  levels of thyroxine,  free fatty  acids, triglycerides and insulin, but  lower  serum  TSH 
and corticosterone concentrations than male  L–E rats [273],  which  also appear  to have 
slightly  higher  levels of plasma  neutral amino acids,  including  tryptophan  [388],  as well as 
higher  plasma  glucose concentrations [409].  In  addition,  our  previous unpublished 
findings,  recently  summarised by  Lensu  et  al.  [204],  support the idea  of differences in 
glucose metabolism  between L–E and H/W  rats: In  contrast  to the H/W  strain,  it  has 
proved impossible to induce diabetes by  streptozotocin (a pancreatic B cell-specific 
toxicant  [356]) administration  to L–E rats, and they  were also unresponsive to 2DG-
elicited eating. Finally, the strains respond differently  to taste and other  “distal cues”  [416] 
in  regulating  meal  size: The H/W rats prefer  saccharin  and drink it more avidly  than  L-E 
rats [276] and,  contrary  to the L–E strain, increase their  total energy  intake when  offered 
palatable food in addition to normal feed [377].
As a more general question, the importance of the hypothalamic  neuropeptides in 
relation to other  systems (inside and outside brain) in  eating  regulation  has not been 
definitively  resolved. Thus, the role of the alterations in  the adiposity  and satiety  signals 
(see 2.4.4) and neurotransmitters other  than neuropeptides (see 2.4.8),  as well as that  of 
the brainstem, reward circuitry  and food aversion  (2.4.7), require further  study  in  relation 
to TCDD-induced energy  balance derailment. Finally, the extent  to which  changes in 
mRNA  expression affect  cellular  protein  abundances is a  moot  point.  Recent studies 
employing  techniques that provide the ability  to directly  survey   mRNA  and protein 
abundances on  a  large scale, suggest  that  only  about  40%  of the variation  in  protein 
concentrations can be explained by  knowing  the mRNA  levels [411], and alterations in 
translation  (not transcription) appeared to be the dominant  mediator  of changes in gene 
expression  during adaptation  to minor  stress in  yeast  cells [121]. On  the other  hand, 
higher  correlations between protein  and mRNA  abundances have also been  observed [63], 
and little is known about  the effects of perturbations in vivo,  let  alone about  the regulation 
of highly  specialised factors such  as neuropeptides,  receptors or  bHLH/PAS proteins.  The 
activated AHR seems to be controlled by  protein  degradation  [143,  144,  219,  274,  288], 
while Ahrr appears to be activated at  the  transcription level [94, 143,  144]. Studies at  the 
protein  expression  level would have been  a  logical step to verify  the mRNA alterations 
detected in studies I and II.  However, the anatomical “robustness”  of the sampling  (whole 
hypothalami) and the minor  alterations detected prompted us not to undertake these 
analyses, but to try to ascertain the reproducibility of the RT-qPCR data.
6.3 RT-qPCR ROBUSTNESS IN TCDD STUDIES
The most  common way  to perform  the critical normalisation  in RT-qPCR is to relate the 
measured mRNA  concentration for  the gene of interest  to the concentration of the 
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reference gene,  or  preferably  to a set  of genes. However, no such  set,  let  alone any  single 
gene,  is universally  suitable for all purposes and must  be validated for each  experimental 
setting,  a  task  attempted in  studies III and IV: First,  the most  stable reference genes in 
response to TCDD or  feed restriction  were sought,  and their  performance in RT-qPCR was 
then  scrutinised.  These technical aspects are both  of particular  importance in  bHLH/PAS, 
neuropeptide and receptor  measurements.  The extremely  heterologous organisation and 
diversity  of function  in hypothalamic  blocks may  well  lead to generally  subdued 
alterations of gene expression  in the absence of a direct  cellular  insult (see discussion in 
previous paragraphs), calling  for  the best  attainable accuracy  and precision  in mRNA 
abundance measurements.
The Actb mRNA  is perhaps the most  widely  employed gene for  normalisation  in  gene 
expression  experiments,  and it was also the only  reference gene resorted to in  studies I 
and II.  The use of a  single gene is generally  not  regarded to be sufficient for  normalisation 
(see 2.5),  but  the inertness of hypothalamic  Actb  expression  after  TCDD treatment  and 
feed restriction was ascertained in  both  studies,  and later  confirmed in study  III, where its 
mRNA  levels remained unchanged in the hypothalamus (and spleen) of fatally  intoxicated 
L–E rats at an  advanced stage of acute toxicity.  All in  all, the use of only  one reference 
gene has most  likely  not  therefore induced marked bias in  the results attained in  studies I 
and II, while it  may  have inadvertently  increased variation  due to the lack of RT stability 
and poor correlation of RT efficiency with the genes of interest, as observed in study IV.
Taken  together,  the findings of study  III substantiate the need for  a  meticulous pre-
validation  of reference genes,  especially  with  dioxins,  whose mechanism  of toxicity 
inherently  involves the readjustment  of gene activities via  the AHR.  However,  even for 
TCDD, it  is still  possible to find normalisation genes that  do not alter their  expression 
levels during  acute intoxication,  and for  the hypothalamus,  Actb,  Sdha, Gapdh  and Pgk1 
all  appear  to be acceptable. On  the other  hand, RT stability  has a  strong  influence on  the 
usability  of the potential reference genes.  The intrinsic RT efficiencies of the ‘‘stable’’ 
Gapdh  and Pgk1 transcripts closely  followed the general transcription  efficiency  in  each 
RT  reaction  and had little variation  besides the general  RT (tube-specific) variability.  In 
contrast,  the ‘‘unstable’’ Sdha  and Actb  transcripts had their  own  independent  intrinsic RT 
efficiencies that  did not correlate with  the general  RT-specific  transcription  efficiency  and 
exhibited somewhat less stability from one RT reaction to another.
Generally,  the covariances of RT efficiency  and RT reproducibility  appear  to be mainly 
gene or  RNA related,  while the RT  enzymes behaved as expected based on their  known 
origins and biochemical  modifications.  Importantly,  the marked lack of covariation  of 
Actb and Sdha  transcription  efficiencies with  the general RT-specific  transcription 
efficiency  and differences in  gene-specific intrinsic  RT  reproducibility  extend the previous 
findings of between-sample gene expression  instability  [268, 354, 363, 395] to RT reaction 
effects, which  bears on  the selection  and use of reference genes to reduce RT reaction 
variation  in  gene expression  measurements by  RT-qPCR; any  statistical method relying  in 
RT  normalisation without  observing  the possible lack of RT  efficiency  covariance between 
the reference genes and genes of interest,  will lead to increased confounding variation 
[361]. The hypothetical  correlation  between  gene-specific  transcription  efficiency  and 
‘‘general’’ RT  reaction  efficiency  appeared to be poor  with  both  a  low  and high  (apparent) 
RNA  transcript  abundance.  However, we did not  assess the secondary  structures (e.g. 
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stem  and loop conformation) of the RNA  transcripts, although these have a  substantial 
impact on the efficiency of reverse transcription and PCR [44].
The RT-to-RT CV  was estimated to be approximately  3  times greater  than  that  of qPCR, 
which  is in agreement with  previous results estimating  the reproducibility  of the RT  step 
to be worse than  that of qPCR [349, 361].  qPCR consistency  remained remarkably  similar 
across the four  transcripts studied,  and the overall  precision  of qPCR was in  excellent 
agreement  with  previous data  [196]. There were appreciable differences in  the 
reproducibility  of the individual qPCR enzymes, but these appear  to be of little 
significance in a  practical analysis setting.  On  the contrary, the salient  differences between 
replicate runs in the qPCR experiment  attest  to an  unexpectedly  large run-to-run 
variation,  and should be taken into account  while analysing  RT-qPCR data. This variation 
appears to be unrelated to the genes or  qPCR enzymes and is most  probably  induced by 
the use of external  standard curves and/or  differences in  pipetting  and the reaction  setup 
between runs.
The complications arising  from  the lack  of technical reproducibility  in  an  RT-qPCR 
experiment  may  (at  least  partly)  be circumvented if the least  precise part  of the study, 
generally  the biological units,  can  be pinpointed and replication  in  this step increased 
[176].  When  an  increase in  the number  of replicates and/or  reference genes is not  feasible, 
a  linear  hierarchical model and Bayesian inference offers the possibility  to build a 
coherent  statistical model of the whole experiment  with  normalisation and error  reduction 
over  all  expression measurements, thereby  maximising  the use of the data.  The hindrance, 
whilst  also an asset,  of the Bayesian  approach  is the necessity  to develop a  unique model 
for  each  experimental setting,  or  at  least  a  careful modification  of a  pre-developed model 
structure, and meticulous consideration  of the prior  probability  distributions of the 
parameters.
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7 CONCLUSIONS AND FUTURE PROSPECTS
1. The small constitutive differences in  the hypothalamic  expression  of Ahr,  Arnt and 
Arnt2  between  L–E and H/W rats are most likely  not  causally  related to the 
development of the wasting syndrome. The induction  of Ahrr expression  and the 
sharp increase in  the  Cyp1a1 and Cyp1a2 mRNA  induced by  TCDD attests to the 
presence of a  functional  AHR signalling cascade in  the hypothalamus,  but warrants 
anatomically  more detailed sampling  of neural, supportive and vasculature-related 
tissue in  order  to establish  the magnitude and importance of cytochrome induction 
in neurons.
2. The lack  of any  drastic  up- or  downward changes in  hypothalamic neuropeptide or 
receptor  mRNA  following  TCDD treatment  and the stability  of hypothalamic 
reference gene expression  in  studies I–III speak against  a  severe cytotoxic  effect  on, 
or  permanent  hyperexcitation  of the cells taking  part in  eating  regulation. The late 
orexigenic elevation  brought  about by  TCDD seems to be a  compensatory  reaction  to 
body  weight  loss,  and an increase in  hypothalamic Agrp expression  appears to be a 
very sensitive response to lowered energy availability.
3. The methods employed in  studies I and II may  cause expression  changes confined to 
a  localised point  and/or  circadian  time to elude detection, and the complex 
neurophysiology  and anatomy  of the hypothalamus may  lead to reciprocal 
cancellation  or  dwindling of alterations.  As a  more general  question,  the importance 
of the hypothalamus in  eating  regulation  in  comparison  to other  systems or  centres, 
especially  reward circuitry,  food aversion and the hindbrain, has not  been 
definitively  resolved. In addition,  the role of alterations in  adiposity, energy  and 
satiety  signals or  their  CNS “interpretation”,  as well as non-peptidergic 
neurotransmission,  requires further  study  in  relation  to TCDD-induced eating 
derailment.
4. In  the wider  context  of energy  balance regulation, the “AHR-unrelated”  genetic and 
physiological differences between  L–E and H/W  strains warrant  further  research. 
The extent  to which  changes in  mRNA  expression  affect  cellular  protein  abundances 
is questionable, and more study  is needed regarding  the level of regulation, 
especially  in vivo,  and concerning  highly  specialised tissues and proteins. However, 
an  unfocused protein or  neurotransmitter  analysis without definite targets, 
anatomical direction or exact timing of sampling is of little value.
5. The number  of genes displaying  acceptable expression  steadiness in  the face of lethal 
TCDD toxicity  is small  (for the hypothalamus,  Actb, Sdha, Gapdh and Pgk1 are 
acceptable), and the RT  stability  has a  strong influence on  the usability  of the 
potential  reference genes,  since the covariances of RT efficiency  and RT 
reproducibility  appear to be mainly  gene or  RNA  related.  The ‘‘unstable’’ transcripts 
have their  own  independent  intrinsic  RT efficiencies that  do not  correlate with  the 
general  RT-specific transcription  efficiency  and exhibit somewhat less stability  from 
one RT  reaction  to another than  the “stable”  transcripts. Hence, the use of only  one 
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steadily  expressed but  unstably  reverse transcribing  reference gene (Actb) has most 
likely  not  induced marked bias in  the results attained in  studies I and II, but  it  may 
have inadvertently increased variation.
6. RT  variance markedly  exceeded qPCR variance, stressing the importance of 
replication  at the RT, or preferably  the biological level, while the consequences of 
appreciable differences in  the reproducibility  of the individual  qPCR enzymes seem 
to be of little practical significance.  On the contrary, the salient  differences between 
replicate PCR runs should be taken  into account  in  the design  and data  analysis of 
RT-qPCR experiments.
7. The use of linear  hierarchical  models and Bayesian  inference in  RT-qPCR data 
analysis offers the possibility  to build a  coherent statistical  model  of the whole 
experiment  with  normalisation  over  all expression  measurements,  thereby 
maximising the use of the data.
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